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Abstract  
Background: Pain related complaints form one of the most common, and most costly, 
presentations of patients in healthcare in New Zealand and worldwide. Theories of pain such 
as the biopsychosocial and fear-avoidance models aim to provide a multidimensional 
framework from which pain can be approached, considering various aspects of how pain 
affects people. The most effective pain management approaches seem to be multimodal and 
patient-specific. The Reinforcement Sensitivity Theory proposes two neurophysiological 
systems that regulate impulsivity and anxiety in human behaviour: the behavioural activation 
system and the behavioural inhibition system. It has recently been suggested that sub-grouping 
individuals affected by pain based on their levels of activation and inhibition could facilitate 
the allocation of more effective management strategies.  
Design: Cross-sectional survey design. 
Aim: To establish which of the following best predicts average intensity and duration of 
musculoskeletal pain: fear avoidance beliefs, kinesiophobia, and levels of behavioural 
activation or inhibition system. 
Methods: Surveys were made available online to adults in New Zealand with pain complaints, 
and to patients at the Unitec Osteopathic Clinic, Clinic 41. Data were gathered over a three-
month period and analysed using Spearman’s rho correlations, linear regressions and a 
between groups analysis assessing for differences between high and low intensity pain and 
levels of behavioural activation or inhibition.  
Results: Correlational analyses showed significant positive relationships between pain 
intensity and fear-avoidance beliefs, kinesiophobia, and disability, as well as between pain 
duration and fear-avoidance, kinesiophobia and perceived disability. Regression analyses 
showed fear-avoidance beliefs, kinesiophobia and disability accounted for 31% of pain 
intensity variance. Disability alone accounted for 5% of the pain duration variance. Neither 
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behavioural activation nor inhibition systems significantly related to or predicted pain 
intensity or duration. 
Conclusion: This study provides further support for the inter-relationships between fear-
avoidance beliefs, kinesiophobia, disability and pain duration and intensity. The results do not 
show explicit support for the behavioural activation or inhibition systems relating to pain 
intensity or duration. It is suggested that this may be due to the measurement instrument, 
which could be explored in further studies.  
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Section 1: Literature Review  
 2 
Literature Review 
The aim of this review of the literature is to provide a rationale for investigating the 
predictive value of behavioural tendencies on pain intensity and duration, and the 
relationship between these variables. This literature review will explore (1) pain 
mechanisms and models, (2) literature assessing current interventions for pain management, 
and (3) what is currently known about the relationship between activation and inhibition 
behavioural tendencies in relation to chronic pain.  
 
Pain 
Mechanisms of Pain 
Pain is a complex phenomenon involving an array of neurological processes, both in the 
peripheral and central nervous systems. Threatening, or noxious, stimuli are conveyed to 
the brain via nociceptive neurons indicating tissue damage (Dubin & Patapoutian, 2010). 
Nociceptive pain is generated by mechanical or thermal stimulation of nociceptive nerve 
fibres in the periphery and is conducted to the central nervous system by two main fibre 
types: unmyelinated C-fibres, and myelinated Að-fibres (Das, 2015; Dubin & Patapoutian, 
2010). These fibres transmit the noxious stimulus to the dorsal horn of the spinal cord, and 
to the cerebral cortex via the spinothalamic tract (Das, 2015; Gebhart et al., 2009). Pain is 
the perception that is subsequently generated by several cortical structures of the brain in 
response to this nociceptive input. These structures include the prefrontal, anterior 
cingulate, somatosensory and supplementary motor cortex, insula, amygdala, posterior 
cingulate and posterior parietal cortex (Moskowitz & Golden, 2013). The brain then 
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responds with up- or down-regulation processes, which may highlight or dampen 
nociceptive signals from the spinal cord (Moskowitz & Golden, 2013). This process of 
initial pain experience is essential to survival as it allows us to form a decision around how 
to react to the threatening stimulus (Dubin & Patapoutian, 2010; Siddall & Cousins, 1997).  
 
Sensitisation and Plasticity  
In addition to supra-threshold stimuli causing pain, pain can also be caused or exacerbated 
by inflammatory mediators secondary to tissue injury (Ji, Xu, & Gao, 2014; Reichling & 
Levine, 2010). Inflammatory mediators, chiefly pro-inflammatory cytokines, can alter the 
responsiveness of peripheral nociceptors. That is, nociceptors can become more sensitive 
meaning non-threatening stimuli can be received as pain. The mechanism by which this 
occurs is a lowering of the nociceptor’s activation threshold (Reichling & Levine, 2010) 
which is commonly referred to as peripheral sensitisation (Siddall & Cousins, 1997). A 
state of hyperalgesic priming, in which a body area remains overly sensitive to 
inflammatory mediators for weeks after the initial insult (Reichling & Levine, 2010), may 
also occur.  
 
Similarly, prolonged nociceptive input to the central nervous system can ‘wind-up’ 
nociceptive pathways (Latremoliere & Woolf, 2009). The increased activity of peripheral 
nociceptive neurons associated with peripheral inflammatory mediators has been suggested 
to contribute to an increased sensitivity of central neurons. This is referred to as central 
sensitisation and occurs through a subsequent rise in the release of neurotransmitters, 
neuromodulators and brain-derived neurotrophic factors (Ji et al., 2014). Once in a state of 
sensitisation, non-painful stimuli are perceived as being painful (allodynia), and stimuli are 
perceived as being more painful than the stimulus warrants (hyperalgesia) (Ji et al., 2014).  
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High threshold or long-term stimulation of nociceptive neurons can lead to modulation of 
neural pain pathways (Ji et al., 2014; Woolf & Salter, 2000). If these modulatory changes 
occur, excitatory synaptic responses become facilitated and synaptic inhibition is depressed, 
thereby amplifying responses to both noxious and innocuous inputs. Neuro-modulatory 
changes are more likely to occur in pain complaints of longer durations. These changes also 
contribute to the development of allodynia; therefore, chronic pain complaints are often 
perceived by the patient as being more intense than the amount of tissue damage warrants 
(Woolf & Salter, 2000). 
 
Classification of Pain States 
Pain is divided into two main pain types depending on the duration: pain that is of less than 
three-month duration is classified as acute pain, while pain that lasts longer than three 
months is classified as chronic, or persistent, pain (Merskey & Bogduk, 1994). For research 
purposes, chronic pain is often classified as being longer than six months' duration 
(Merskey & Bogduk, 1994). Subacute and subchronic pain states also exist, with subacute 
pain referring to a pain duration more than five to seven weeks but not more than 12 
(Bogduk, 1999). Subchronic pain may similarly begin at five to seven weeks duration but, 
in contrast to subacute pain, is defined as lasting longer than 12 and not more than 52 
weeks (Fryer, Alvizatos, & Lamaro, 2005).  
 
Acute pain is typically the result of a specific injury or insult to the body. This pain serves 
to evoke a reaction, such as reflexive avoidance of the painful stimulus and is, therefore, 
necessary for survival. Although there is no absolute correlation between pain and tissue 
damage, in acute pain states the pain sensation experienced is generally in proportion to the 
amount of tissue damage sustained (Eccleston & Crombez, 1999; Gebhart et al., 2009). 
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Once the nociceptive stimulus is removed and the injury heals, the pain subsides (Grichnik 
& Ferrante, 1991). As acute pain is more likely to be indicative of tissue damage, the 
development of avoidance behaviours and fear of movement or re-injury (kinesiophobia) 
can be helpful in minimising any further damage to the injured area. In chronic pain states, 
however, these aversive behaviours can become mal-adaptive, affecting physical 
functioning, e.g. in work, recreation and mood (Zale & Ditre, 2015).  
 
In contrast to acute pain, chronic pain is often suggested to outlast the expected time of 
healing. Perhaps a key factor in the presentation of chronic pain complaints is that the pain 
can exist or worsen without any external stimulus at all (Apkarian, Hashmi, & Baliki, 
2012). It has been noted in cases of post-traumatic stress disorder that this occurs as a result 
of central sensitisation (Latremoliere & Woolf, 2009). Apkarian and colleagues' (2012) 
reviewed functional and structural magnetic resonance imaging studies of chronic pain. 
Results showed a decrease in grey matter density and some alterations in white matter 
connectivity. In addition, chronic pain was shown to be elicited in different areas compared 
to acute pain states: the medial anterior cingulate cortex rather than the anterior cingulate 
were implicated in chronic pain, and there was an absence of insula activation unless a 
spike in the intensity of chronic pain was experienced. The authors further discussed how 
unremitting pain stimuli could contribute to a learning state whereby normal environments 
become associated with pain. Chronic pain sufferers are then not able to unlearn these 
environmental pain associations, as the pain does not cease long enough or often enough 
for them to not reinforce these negative associations. This in turn impacts on the limbic 
system, which contributes to the emotional response to pain, and the descending 
modulation as the brain continues to remind the body that this pain is negative and 
threatening.  
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This theory can be applied to cases of chronic low back pain. Low back pain is a common 
complaint in both acute and chronic states (Hoy et al., 2012). In the acute phase it can be 
self-limiting (Patrick, Emanski, & Knaub, 2014). However, complaints of low back pain 
often recur and are then classified as chronic conditions (Hoy, Brooks, Blyth, & 
Buchbinder, 2010). A fMRI study compared neuronal activation responses to pain, as well 
as subjective pain report, in chronic low back pain sufferers, fibromyalgia sufferers and 
healthy control subjects (Giesecke et al., 2004). Compared to controls exposed to the same 
pressure, chronic low back pain and fibromyalgia patients reported higher pain intensity 
and exhibited more neuronal activation in pain areas in the brain (specifically the 
contralateral primary and secondary somatosensory cortices, inferior parietal lobule, 
cerebellum, and ipsilateral secondary somatosensory cortices). This implicates central 
processes rather than peripheral as the driver of these chronic pain states. 
  
It has also been proposed that there may be a genetic component contributing to individuals 
susceptibility to developing chronic pain (Hartvigsen et al., 2009; Van Hecke et al., 2017; 
Vehof, Zavos, Lachance, Hammond, & Williams, 2014). This proposal has particularly 
featured in discussions of chronic pain syndromes such as fibromyalgia and irritable bowel 
syndrome (Vehof et al., 2014; Voscopoulos & Lema, 2010). The heritable component of 
chronic pain conditions is most easily demonstrated in populations of twins (Hartvigsen et 
al., 2009; Vehof et al., 2014), but has also been shown in generational groups (Van Hecke 
et al., 2017). Some of the key genes that appear to be common to musculoskeletal pain 
include catechol-O-methyltransferase (COMT), and beta-2 adrenergic receptor (ADRB2) as 
part of the catecholaminergic system, as well as serotonin receptor 2A (HTR2A) and 
serotonin transporter (SLC6A4) as part of the serotonergic system (Zorina-Lichtenwalter, 
Meloto, Khoury, & Diatchenko, 2016). Also, not specific to musculoskeletal pain, mu 
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opioid receptor (OPRM1), guanosine triphosphate cyclo-hydrolase (GCH1) and all human 
lymphocyte antigen (HLA) groups have been implicated in pain genetic research (Mogil, 
2012).  
 
Psychosocial factors such as fear-avoidance beliefs, fear of re-injury, catastrophic thoughts 
and traits of anxiety and neuroticism are also linked with both the development and 
maintenance of chronic pain states – though it is not clear whether these pre-date the pain 
complaint, or develop as a result of persistent pain (Voscopoulos & Lema, 2010). The term 
fear-avoidance encompasses a range of beliefs that centre around a fear of pain and the 
belief that movement is detrimental (Parr et al., 2013; Gordon Waddell, Newton, 
Henderson, Somerville, & Main, 1993). Fear-related avoidance of movement in response to 
pain may be a beneficial adaptation in acute pain states as a self-preservation mechanism, 
however these beliefs enduring into chronic pain states become mal-adaptive (Gatchel, 
Peng, Peters, Fuchs, & Turk, 2007). Kinesiophobia is a subset of fear-avoidance that is 
specific to fear of injury, or re-injury – fear of movement itself, as opposed to fear relating 
to beliefs about movement in general (Parr et al., 2013). Catastrophising can also contribute 
to prolonging and worsening the pain experience, as it is characterised by over-
exaggerating of the negative aspects of pain, and inability to disengage from ruminating on 
the pain experience (Sturgeon & Zautra, 2013). The presence of these mal-adaptive 
psychosocial variables has been shown to relate to longer pain duration and more disability 
(Denison, Åsenlöf, & Lindberg, 2004; Parr et al., 2013; Vranceanu et al., 2014). 
 
The number of pain sites, rather than the specific location of pain, is yet another factor that 
has been suggested to increase the risk of chronicity (Mallen, Peat, Thomas, Dunn, & Croft, 
2007). It has been suggested that considering the primary site of pain (for example, low 
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back or shoulder) does not lend much predictive ability to prognosis. Rather, the number of 
pain sites has been found to relate to prognosis, with more sites of pain indicating longer 
duration (de Vos Andersen, Kent, Hjort, & Christiansen, 2017). Having multiple sites of 
pain has also been shown to relate to decreased ability to work, a higher number of sick 
days and an increased intention toward early retirement (Miranda et al., 2010). 
 
Burden of Pain 
Pain is common to all genders, age ranges and ethnicities. In the section that follows, trends 
between these determinants and pain will be summarised. There appears to be a consensus 
that women report more chronic widespread pain (such as fibromyalgia) severe and 
frequent pain and pain of longer durations as compared to men (Henschke, Kamper, & 
Maher, 2015; Mansfield, Sim, Jordan, & Jordan, 2016). However, low back pain 
specifically is more commonly reported in men (Driscoll et al., 2014). The age group most 
affected by pain is reported to be slightly different in different studies. Some suggest that 
pain increases throughout adulthood (Fayaz, Croft, Langford, Donaldson, & Jones, 2016), 
others that there is a peak around 60 years of age, after which the prevalence of pain 
reaches a plateau (Mansfield et al., 2016). Another suggestion is that there is a spike in the 
prevalence of pain in middle-aged adults (35 – 55 years) and again in old age (Henschke et 
al., 2015). As the points of highest pain prevalence are in middle and late adulthood, there 
has been some concern raised over the ageing population that will see the level of pain-
related complaints continue to rise (Fayaz et al., 2016).  
 
Culturally, pain is perceived in varying ways. Western cultures tend to take a 
biomechanical approach where pain is considered to be the result of a pathological process 
that can be repaired, thereby resolving pain. If no pathological cause can be identified, the 
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cause is assumed to be psychological in nature (Ho & Johnson, 2013). Eastern cultures, 
specifically traditional Chinese medicine, take a more holistic approach. Ailments are 
thought to be caused by both external pathogenic factors and internal imbalances specific to 
the individual (Ho & Johnson, 2013). In New Zealand, Māori culture takes a similar stance 
whereby pain is perceived to affect physical, psychological, social, and spiritual aspects of 
life (Magnusson & Fennel, 2011). Alongside varying cultural views on pain, there are 
differences in pain prevalence between different ethnic groups. The largest burden of 
disability secondary to work-related low back pain was found to be in East Asia, South East 
Asia, and, on a per capita basis, Oceania (Driscoll et al., 2014). There also may be more 
chronic widespread pain in a Southeast Asian population than in the European population 
(Mansfield et al., 2016). There have been reports of higher pain prevalence in American 
Indians, Alaska Natives, and Aboriginal Canadians compared to a general United States 
population (Henschke et al., 2015). Additionally, prevalence reports in Africa are slightly 
higher than those in Western countries (Henschke et al., 2015).  
 
Statistics demonstrating the incidence and prevalence of pain complaints are variable. 
However, there is no doubt that pain is common, costly and has a negative impact, both on 
a large scale and on an individual level (Henschke et al., 2015). Reports of new incidences 
of low back pain, for example, can range from 1.5% to 38.9% over one year, with 
recurrence at one year ranging from 24% to 80%. Low back pain is one of the more 
commonly documented and studied pain complaints with the estimated prevalence of low 
back pain ranging from 24-49.5% (Henschke et al., 2015). Comparably, the prevalence of 
thoracic pain is estimated to be between 1.4-34.8%, and neck pain between 15.4-45.3%. 
Prevalence of chronic low back pain is lower than other low back complaints, but still 
remarkably common between 5.9-18.1%. It is estimated that chronic pain (not specific to 
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the low back) affects 16% of New Zealand adults (Swain & Johnson, 2016). The high 
variability in these numbers has been suggested to be due to lack of clarity in reporting 
regarding definitions of episodes, time periods assessed and prevalence (Henschke et al., 
2015).  
 
The financial cost of pain is multifactorial and includes aspects such as the national cost of 
healthcare, the loss of productivity through work absenteeism and personal cost of 
healthcare and support work (Henschke et al., 2015; Pearce et al., 2004). Managing chronic 
pain is one of the highest healthcare costs on a global scale (Henschke et al., 2015). 
Considering statistics gathered by New Zealand’s Accident Compensation Corporation 
(ACC), the cost of all pain complaints brought on as a result of injury among New 
Zealanders was approximately $2.2 billion for 1.7 million new claims and 1.5 million pre-
existing claims active in 2016-2017 (ACC, 2017). An Australian report estimated the cost 
of chronic pain per annum amounted to $10,847 per person (Access Economics, 2007). 
Another report estimated that older adults (ages 45-64 years) not working due to poor 
health decreased Australia's gross domestic product by as much as $14.7 billion per annum 
(Schofield, Shrestha, Passey, Earnest, & Fletcher, 2008). Comparing the cost of pain-
related complaints to that of other health complaints, the total cost of chronic pain in the 
USA in 2010 was between $560 - $635 billion; the cost of heart disease was closer to $309 
billion, cancer $243 billion, and diabetes $188 billion (Gaskin & Richard, 2012).  
 
In addition to the financial cost of pain, there is also often a personal cost to consider. 
Chronic pain can affect a number of psychosocial variables including mental health, 
physical ability, ability to work and ability to contribute to society (ACC, 2004; Henschke 
et al., 2015). Common mental health issues associated with chronic pain include 
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depression, anxiety, low self-efficacy and poor general emotional functioning (Burke, 
Mathias, & Denson, 2015). A meta-analysis by Burke, Mathias, and Denson (2015) found 
that while depression is a common psychological problem in adults experiencing chronic 
pain, they consistently report higher levels of anxiety. This suggests anxiety to be the 
foremost mental health variable affected by chronic pain. A review by Froud et al. (2014) 
highlighted some key themes in assessing the personal impact of low back pain. The first 
theme was that people affected by low back pain were no longer able to carry out all their 
activities of daily life, such as domestic chores and leisure activities. The second theme 
detailed the negative impact pain had on the participant's relationships, including familial 
relationships, sexual relationships and social life, leading to feelings of isolation and being 
burdensome on others. The third theme was work-related. Not only were there concerns 
about the number of sick days and fear for the loss of employment, there was also anxiety 
relating to workplace socialising and concerns regarding finance.  
 
Models of Pain 
There are several models conceptualising pain, some of the more prominent models include 
the biomedical, biopsychosocial, and fear avoidance models of pain.  
 
The biomedical model of pain is one of the older models of pain, being most popular prior 
to the 1980s (Engel, 1980). It focuses primarily on providing a biological explanation for 
pain by considering the nociception and physiology that contributes to pain as a sensation 
that can be measured (Engel, 1980). This pathoanatomical consideration of pain is still 
widely used and can be clinically convenient as it provides a starting point from which the 
patient can be further examined. However, it has been argued that this model is reductionist 
as it fails to encompass the complexity of the pain experience (Bendelow, 2013). 
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Additionally, when a diagnosis focusses on an injured tissue or structural abnormality, it 
has been suggested that any negative beliefs the patient holds can be further reinforced 
(Darlow, 2016). In the case of chronic and idiopathic pain, the argument against use of the 
biomedical model is that does not account for psychosocial contributions, such as fear, to 
an individual’s pain experience (Bendelow, 2013; Leeuw et al., 2007). In response to this, 
the biomedical model of pain was expanded by Engel (1977) into the biopsychosocial 
model of pain which includes psychological and social contributors to pain experience 
(Crombez, Eccleston, Damme, Vlaeyen, & Karoly, 2012).  
 
It is now widely accepted that pain experience is influenced by a multitude of factors 
ranging from the structure and sensitivity of the nervous system to emotional state and 
societal norms (Moseley, 2007; Voscopoulos & Lema, 2010). The “bio” element of the 
biopsychosocial model relates to the physiological processes involved in the perception of 
pain. These include genetic predisposition to different pain phenotypes (such as pain 
location and duration) (Hartvigsen et al., 2009), sensitisation processes of peripheral and 
central neurons, as well as alterations to brain structure in response to persistent pain 
(Apkarian et al., 2012; Ji et al., 2014).  
 
There are many possible elements that could be considered important within the 
biopsychosocial model of pain. Some of the more prominent ones include catastrophising, 
fear-avoidance beliefs, and self-efficacy (Gatchel et al., 2007). Denison, Åsenlöf, and 
Lindberg (2004) found that high pain intensity and low self-efficacy were both significantly 
predictive of disability in a sub-acute and chronic musculoskeletal pain population (n=371). 
They also found that the presence of disability had significant positive relationships with 
fear-avoidance beliefs of catastrophising and kinesiophobia, and a significant negative 
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relationship with self-efficacy. Vranceanu et al. (2014) found strong interrelationships 
between catastrophising, pain anxiety, post-traumatic stress and depression in 136 patients 
after skeletal trauma. Furthermore, all these variables were also significantly related to pain 
intensity and disability (Vranceanu et al., 2014).  
 
The biopsychosocial model also incorporates how social connection is important when 
considering pain and pain management. As an example, positive social interaction, either 
verbal or non-verbal, has been found to reduce pain, while negative or ambiguous 
interaction increases pain (Krahé, Springer, Weinman, & Fotopoulou, 2013). Similarly, 
active and passive support have both been found to reduce the intensity of experimentally 
induced pain, regardless of whether it is provided by a known or unknown person (Brown, 
Sheffield, Leary, & Robinson, 2003). Beyond singular interactions, having a social support 
network has been shown to decrease depression and moderate pain in a longitudinal study 
of elderly persons (Lee, Kahana, & Kahana, 2016). These demonstrate the important 
positive effects of having social support and social interaction on pain. Socialisation has 
recently been found to directly relate to mortality. People with good quality and larger 
quantities of social interactions demonstrated 50% increased likelihood of survival compare 
to those lacking in substantial social relationships (Holt-Lunstad, Smith, & Layton, 2010). 
However, despite socialisation being helpful for reducing pain intensity and an important 
factor in contributing to length of life, social interactions can also have a negative effect on 
pain.  
 
Darlow (2016) discusses the effect clinician and community beliefs and behaviours can 
have on patient’s beliefs and outcomes, specific to low back pain. Clinicians with fear 
beliefs about pain, or who advise rest and caution in activities are more likely to reinforce 
 14 
these beliefs in patients. The effect of community beliefs can also be very impactful 
(Darlow, 2016). Wider community beliefs about low back pain are not constructive, with 
many believing that the low back is inherently weak, that pain indicates damage and will 
lead to increased weakness of the injured part, that exercise can be detrimental, and that 
pain during exercise indicates those movements should be avoided (Darlow et al., 2014; 
Gross et al., 2006; Ihlebæk & Eriksen, 2003; Munigangaiah, Basavaraju, Jadaan, Devitt, & 
McCabe, 2016). This indicates a global deficit in informed and constructive beliefs about 
low back pain, management and prognosis which, in turn, has negative ramifications for 
those experiencing low back complaints (Darlow, 2016). Negative social influences on pain 
have also been shown on a more personal level. By assuming a role of ‘carer’, the beliefs of 
spouses and partners can reinforce fear of reinjury and disability in the pain sufferer 
(Brooks, McCluskey, King, & Burton, 2013).  
 
Pain can have a significant impact on social factors as well. A systematic review of 42 
studies by Froud et al. (2014) considered how pain affected patient’s lives. The themes 
reported include disruption of domestic and recreational activities, negative impact on 
relationships, negative impact on work, coping with social stigma, and the need to change 
their outlook on life to accommodate for the pain that is seemingly not changing. They 
overlap with the aforementioned psychological variables, as many of them result in the 
patient having fears about their pain or future with pain, having catastrophising thoughts 
and depression or feelings of hopelessness.  
 
The fear-avoidance model of pain builds further onto the role that fear can have on pain 
experience. It centres around the idea that fear of pain, movement and injury, and 
associated beliefs about pain appear to be associated with chronic musculoskeletal pain 
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complaints (Lucchetti, Oliveira, Mercante, & Peres, 2012). These mal-adaptive beliefs, for 
example, fear-avoidance, catastrophising, and kinesiophobia have been suggested to act in a 
cycle of perpetuating chronic pain (Crombez, Eccleston, Damme, Vlaeyen, & Karoly, 
2012; Vlaeyen & Linton, 2000). Fear of pain may lead to avoidance of activity, in turn 
reinforcing disuse and disability as well as depression, which potentially negatively 
moderates the pain perception, serving to increase fear of pain (Leeuw et al., 2006). It is not 
unreasonable to surmise that such cycle could be detrimental to the physical health of 
patients, and indeed could potentially exacerbate pain (Jensen, Ehde, & Day, 2016). 
Measuring these factors may be relevant in a chronic pain scenario as addressing fears 
around movement and (re)injury may help to break the cycle. 
 
Considering patient’s complaints from a biopsychosocial or fear-avoidance perspective 
allows for a more complete assessment of the pain experience. Acknowledging these 
different elements of pain, such as patient’s beliefs, coping strategies and socio-economic 
status, results in a more patient-centred approach to treatment and pain management 
interventions (Vlaeyen et al., 2007). Some common pain management interventions are 
discussed below.  
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Interventions: Managing Pain 
Though the prevalence of pain-related complaints appears to be rising, there are a number 
of methods commonly in use to treat pain. The first and perhaps most common is 
pharmaceutical management. Secondly, there are several modes of manual therapy that are 
often used in injury rehabilitation and pain management. Thirdly, psychological techniques 
such as cognitive therapy and educational approaches, among others, have become popular 
– particularly in managing chronic pain complaints. In the following, each of these 
approaches is outlined briefly, and recent research examining the mechanisms and 
effectiveness of the approaches is summarised. 
 
Pharmaceutical pain management 
Pharmaceutical drugs are commonly used in cases of acute, post-operative and persistent 
pain primarily for symptomatic management (Machado et al., 2015; Machado et al., 2017). 
There are several approaches utilised to achieve a reduction in pain. Non-opioids, including 
non-steroidal anti-inflammatories (NSAIDs) and Paracetamol, are often the first line of 
treatment. These drugs aim to have analgesic, anti-inflammatory and antipyretic effects. 
Reducing inflammation, and subsequently inflammatory mediators such as cytokines, helps 
to limit the development of hyperalgesia and allodynia (Gebhart et al., 2009). The next 
level of pharmaceutical pain management involves opioid drugs. These induce a stronger 
analgesic effect, however, due to a large number of adverse side effects, are only utilised in 
more severe cases (Park & Moon, 2010). Antidepressants including selective serotonin re-
uptake inhibitors and norepinephrine-serotonin re-uptake inhibitors a more commonly used 
in chronic or centralised pain scenarios as analgesic effects are targeted at the spinal cord 
and may take several weeks to occur. A secondary mode of action is the anti-depressive 
effect that leads to small decreases in pain perception (Park & Moon, 2010). 
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Antidepressants are commonly used in conjunction with anticonvulsants such as 
Gabapentin where pain is believed to be of neuropathic origin. Finally, muscle relaxants 
such as Baclofen are utilised where muscle spasticity is assumed to take a primary role in 
pain generation (Park & Moon, 2010). A major role of pharmaceutical management of pain 
is to disrupt the nociceptive pathways. This can help to reduce the risk of developing 
peripheral and central sensitisation which can contribute to chronic pain complaints 
(Gebhart et al., 2009).  
 
Although pharmaceutical management has been considered a superior approach, more 
recent evidence suggests that it may not always be effective (Machado et al., 2015). For 
example, Paracetamol may not constitute the best course of first-line treatment for non-
specific spinal pain complaints. A systematic review and meta-analysis by Machado et al. 
(2015) provide high quality evidence to suggest that Paracetamol is not effective in 
reducing pain in those with low back pain complaints (both acute and chronic 
presentations). Furthermore, regular users of Paracetamol were four times more likely to 
have abnormal liver function test results compared to those not using Paracetamol, which 
should be considered in cases of high dose and long-term usage (Machado et al., 2015). 
Similarly, there is recent research suggesting non-steroidal anti-inflammatory drugs 
(NSAIDs) are no more effective than placebo in treating acute or chronic spinal pain 
(Machado et al., 2017). A review by Machado et al. (2017) found that the analgesic effects 
of NSAIDs were not significantly different from the pain reduction gained by taking only 
the placebo. Machado et al. (2017) note concerns about adverse events, mainly relating to 
the cardiovascular safety of using NSAIDs that target cyclooxygenase-2 (COX-2) 
inhibitors, and common gastrointestinal damage.  
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The rate of opioid prescription has been rising over the past years (Levy, Paulozzi, Mack, & 
Jones, 2015; Olsen, Daumit, & Ford, 2006), and subsequently the associated risks are 
becoming increasingly discussed (Chou et al., 2015). There are specific concerns relating 
long term use with addiction and death following opioid overdose (Levy et al., 2015), as 
well as reported adverse effects such as increased reported fractures, myocardial infarctions 
and endocrinological harm (Chou et al., 2015).  
 
These findings suggest that, although pharmaceutical management of pain is common and 
may be effective in the short-term, long-term use of any of the aforementioned drugs is not 
helpful in reducing pain. Patients aiming to treat persistent pain complaints must, therefore, 
look to alternative avenues to find relief. One such avenue that is becoming more popular is 
that of manual therapies.  
 
Manual therapy for pain management 
Physical interventions are often used in the management of pain complaints alongside or as 
an alternative to pharmaceutical interventions. While these treatment modalities have 
grown considerably in popularity, they are still commonly termed complimentary 
treatments (Fredin & Lorås, 2017; Licciardone, Brimhall, & King, 2005). Treatment can 
include a range of approaches, from exercise prescription and ergonomic adjustments to 
manual treatment such as osteopathy, chiropractic and physiotherapy (Keeffe et al., 2016; 
Tsertsvadze et al., 2014). These manual treatments typically involve some mixture of spinal 
manipulation, joint articulation or mobilisation and soft tissue massage type techniques, 
amongst others, that are selected based on findings of a physical examination (Tsertsvadze 
et al., 2014).  
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A systematic review by Hidalgo, Detrembleur, Hall, Mahaudens, & Nielens (2014) 
evaluated 23 randomised controlled trials and found general manual therapy and 
combination treatments to be more beneficial than usual medical care or exercise alone for 
non-specific low back pain. Specifically, spinal manipulation was more effective compared 
to sham treatment and resulted in short-term (1-3 month) pain reductions for acute, 
subacute and chronic pain. Moderate quality evidence suggested that soft tissue techniques 
and spinal manipulation combined with either exercise or other usual medical care was 
better for improving pain, function, and quality of life in both the short and long term when 
compared to exercise interventions alone in cases of chronic pain. Finally, the authors 
report limited evidence of soft tissue and joint mobilisation techniques combined with usual 
medical care improving pain and function when compared to usual medical care alone.  
 
Licciardone et al. (2005) reviewed six randomised controlled trials assessing the efficacy of 
osteopathic manual treatment specifically for low back pain complaints. Osteopathic 
treatment was found to significantly reduce pain at short and long-term follow-ups (three 
months) in the United Kingdom and the United States of America, compared to active 
treatment, placebo control, or no treatment. As with the pharmaceutical interventions, 
manual therapies for pain management do involve some element of risk. For example, 
adverse events recorded by Paige et al. (2017) included the manual treatment itself being 
painful, increases in pain for 1-2 days post-treatment and an increased sense of fatigue and 
stiffness, though these were all transient and only reported in the minority. 
 
A further study assessing treatment outcomes of physiotherapy for musculoskeletal pain 
reported statistically and clinically significant benefits (de Vos Andersen et al., 2017). 
Participants who were more satisfied with their treatment outcomes were likely to be older 
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or retired persons with less pain intensity and pain for a shorter duration, less disability, less 
fear-avoidance, persons without compensations claims, non-smokers, and those in better 
mental health. Many of these are the type of psychosocial variables that have been found to 
relate to chronicity, disability and depression (Froud et al., 2014). Interestingly, de Vos 
Andersen et al. (2017) did not find any specific injury or pain site to be related to more 
intensity or longer duration of pain, which further supports the significant role that 
psychosocial variables can play in pain experience.  
 
These articles outline that manual treatments can reproducibly reduce pain, at least over a 
short-term period of up to three months. Manual therapy has some risks associated, as do 
the pharmaceutical approaches for pain management, however these negative effects are 
not common and are transient in most cases. Given that the most burdensome form of pain 
is persistant or chronic pain (Henschke et al., 2015), a long-term solution is still sought 
after. 
 
Psychology 
Manual therapy sessions allow for an interplay of symptomatic changes, therapeutic 
relationship and health and illness beliefs, which may positively influence their efficacy 
(Bradbury, Bishop, Yardley, & Lewith, 2013). There is considerable evidence to suggest 
that fear and anxiety regarding pain, in fact, make the pain worse – both more intense and, 
in some, more debilitating (Denison et al., 2004; Vranceanu et al., 2014). Many cognitive-
based pain management strategies are becoming more popular for treating chronic pain 
conditions, alongside the more traditional approaches (Beck & Dozois, 2011). Some of the 
more widely known psychological interventions include cognitive behavioural therapy, 
educational approaches such as Explain Pain, and mindfulness-based interventions.  
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Cognitive behavioural therapy is an activity-based psychological intervention for pain 
management first devised by Beck (1963). There is no specific protocol for this treatment; 
instead, any combination of strategies may be used based on the clinician's judgement 
(Ehde, Dillworth, & Turner, 2014). Cognitive behavioural activities are typically based on 
cognitive tasks, such as keeping a daily record of thoughts allowing patients to recognise 
automatic thoughts and critically assess the validity and helpfulness of those thoughts; or 
behaviour specific tasks, for example, the patient makes a statement about an activity, then 
carries out the activity, and finally reassess the initial statement for accuracy (Beck & 
Dozois, 2011). Other activities can include relaxation training, activity-based goal setting, 
problem solving and activity pacing guidance. There are often also activities that are given 
for between-session practice. A Cochrane review by Williams, Eccleston, & Morley (2012) 
found that cognitive behavioural therapy had the largest positive effect on patients mood, 
both directly after treatment and at follow up. There was a small positive effect on 
catastrophising and disability when compared to active controls. A positive effect on pain, 
disability, mood and catastrophising was also reported when compared to usual treatment 
and wait list controls. This suggests that, although there is not a strong link between 
cognitive behavioural therapy and pain reduction, this treatment approach lessens 
psychosocial aspects that can worsen the impact of pain, such as catastrophising.  
 
A more recent review by the same group, Eccleston, Morley, & Williams (2013) reviewing 
42 studies with a cumulative total of 4788 adults experiencing musculoskeletal pain, found 
that cognitive behavioural therapy was effective in reducing pain and disability 
immediately after treatment. They were not able to ascertain how enduring such treatments 
were but did note that the initial effect size was small. Specific cognitive behavioural 
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treatments targeted at anxiety-driven thought patterns had more promising results, with 
reduced catastrophising thoughts and fear about current and future pain. Both these reviews 
concluded that, while there was some reduction in pain intensity, cognitive behavioural 
therapy provides an improvement in the quality of life through a reduction in 
catastrophising thought patterns and disability. 
 
Another psychological intervention growing in popularity is the Explain Pain educational 
approach by Butler and Moseley (2003). Again, this does not refer to one specific 
intervention, but a group of different therapeutic approaches with the core goal of helping 
patients to understand their pain. More specifically, patients are guided in the understanding 
of the biological mechanisms of pain. The aim of this is to reduce the opinion that pain is 
inherently negative and threatening, but rather a protective biological mechanism (Moseley 
& Butler, 2015). A review of eight articles studied the efficacy of neuroscience education 
for adults suffering from chronic musculoskeletal pain (Louw, Diener, Butler, & 
Puentedura, 2011). Four of the included articles cited Butler and Moseley's Explain Pain 
text specifically in guiding the educational interventions. Regardless of the specific 
educational resource, the educational approach showed positive effects on reducing pain, 
disability, anxiety and stress across all of the reviewed studies (Louw et al., 2011). 
 
Mindfulness is yet another cognitive based therapy that has been shown to be effective in 
managing pain complaints (Gotink et al., 2015). Developed by Jon Kabat-Zin in 1979, 
Mindfulness interventions promote an attention to internal and external experiences as they 
occur and without judgement (Gotink et al., 2015; Veehof, Trompetter, Bohlmeijer, & 
Schreurs, 2016). Acceptance and commitment therapy focuses on one aspect of 
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Mindfulness, that is acceptance of the pain and of the current state of ability rather than 
ruminating (Veehof et al., 2016). 
 
Mindfulness-based interventions have been effective in reducing pain intensity in chronic 
pain populations (Reiner, Tibi, & Lipsitz, 2013). As well as acceptance therapy, the specific 
interventions analysed in this review of 16 studies included mindfulness-based stress 
reduction, mindfulness meditation and emotional regulation therapy. The positive results of 
reduced pain intensity were of moderate effect size. The authors hypothesised that the cause 
for pain reduction was not due to any effect on biological processes, but rather to the 
promotion of positive thought patterns helping to lessen the emotional impact of pain 
(Reiner et al., 2013).  
 
Further review by Gotink et al. (2015) of 115 individual studies supports that mindfulness 
can be helpful in improving physical function and quality of life, while reducing stress and 
anxiety. Additionally, they suggest that undertaking mindfulness-based therapies can have a 
prophylactic effect against the development of chronic pain in healthy children and adults 
alike. In a comparison, cognitive-based therapies were found to provide more effective 
results in decreasing depression, pain interference and disability than mindfulness-based 
interventions, however, the authors support mindfulness as a useful adjunct to traditional 
treatment (Veehof et al., 2016). 
 
These summaries of current literature regarding pharmaceutical, manual and psychological 
interventions are positive, suggesting that each intervention has a role to play in pain 
management. Elements of the psychological interventions can be incorporated into manual 
treatments either directly or indirectly. Directly, it is possible for manual therapists to 
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undertake additional training in the field of psychology (Hill et al., 2011). Indirectly, it is 
known that the clinician’s own beliefs surrounding pain, injury and disability can impact on 
patients’ health and illness beliefs (Bradbury et al., 2013; Darlow, 2016). Therefore, further 
education regarding the biopsychosocial influences on and impacts of pain could help 
promote more positive outlook on pain management and rehabilitation. Specifically, 
reassuring the patient that the cause of pain is not a serious injury and being very clear on 
which activities can be undertaken, rather than those that should be avoided. Appreciation 
of cultural background can positively impact the way patients interact with healthcare 
professionals and intervention outcomes (Swain & Johnson, 2014). Multidisciplinary or 
tailored treatment approaches are suggested to give patients the most appropriate 
management for them, balancing physical and psychological interventions as required 
(Burton et al., 2005; Hill et al., 2011; Keeffe et al., 2016).   
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Pain and Behaviour  
Alongside biopsychosocial considerations of pain, there is an increasing awareness of how 
behavioural tendencies can influence the pain experience. The Reinforcement Sensitivity 
Theory, born out of attempts to understand anxiety disorders, proposes two neurobiological 
systems that regulate impulsivity and anxiety in human behaviour (Gray, 1970). The first of 
the two systems, the Behavioural Approach or Activation System (BAS), is thought to 
regulate impulsivity. The second, the Behavioural Avoidance or Inhibition System (BIS), 
purportedly regulates anxiety (Gray & McNaughton, 2000). This theory and its behavioural 
systems have since been linked to personality traits, positive and negative affect and pain 
(Jensen, Tan, & Chua, 2015; Kennis, Rademaker, & Geuze, 2013). The Reinforcement 
Sensitivity Theory further suggests that individual’s responses to external stimuli through 
either the activation or the inhibition system is partially innate and partially based on learnt 
experiences. Crucially, this means that the degree to which a response may be dominated 
by the activation or inhibition system may be responsive to education or cognitive therapies 
(Jensen et al., 2016).  
 
The activation system contributes to approach behaviours, goal achievement and 
pleasurable outcomes in response to innate and learnt positive stimuli. In contrast, the 
inhibitory/avoidance system contributes to a more cautious approach and withdrawal 
behaviours in response to threatening or negative stimuli. The inhibition system has also 
been suggested to have the ability to override the activation system if the perceived threat is 
great enough (Jensen et al., 2016). Dominance of the inhibition system has been linked with 
personality traits of negative affect, neuroticism and anxiety, whereas dominance of the 
activation system has been linked with extraversion and positive affect (Campbell-Sills, 
Liverant, & Brown, 2004; Carver & White, 1994). 
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Physiologically, the inhibition system exists primarily as a pathway through the amygdala, 
(Gray & McNaughton, 2000; McNaughton & Corr, 2004). This area is known to be 
involved in acute pain perception (Moskowitz & Golden, 2013), fear conditioning, 
emotional learning and memory (Balleine & Killcross, 2006). Other brain areas may 
become involved depending on the intensity of a perceived threat (Kennis et al., 2013). The 
activation system includes the basal ganglia (Gray & McNaughton, 2000; McNaughton & 
Corr, 2004), a group of nuclei that create a network within the forebrain (Utter & Basso, 
2008). They are most notably involved in the dopaminergic circuit, which is linked with 
movement, and reward detection, response to positive stimuli and in motivation to achieve 
a goal (Corr, 2013; Gray & McNaughton, 2000; Jensen et al., 2016; McNaughton & Corr, 
2004). In addition, the left prefrontal cortex, an area associated with “approach” emotions 
(such as happiness and anger) is considered part of the activation system. Conversely, right 
prefrontal brain areas associated with “withdrawal” emotions (such as anxiety and sadness) 
may form part of the inhibition system (Jensen et al., 2016).  
 
The emotional and motivational relationship of each behavioural system has been 
demonstrated by Balconi, Falbo, and Conte (2011). Alongside Carver and White's 
BIS/BAS Scale (1994b), they assessed participants heart rate, skin conductibility, and 
muscle activity. They found, as predicted, that those who scored highly in BAS responded 
more strongly to positive images, whereas those who scored highly in BIS responded more 
highly to negative images or patterns. BIS participants were also found to be more sensitive 
to negative emotional cues.  
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BIS-BAS Model of Chronic Pain 
Research by Jensen and colleagues (Jensen et al., 2015, Jensen et al., 2016, Jensen et al., 
2017) has recently extended the Reinforcement Sensitivity Theory to the perception of 
pain. Specifically, the authors suggest that an individual’s pain response can result 
primarily from, and be modulated by, the activation or the inhibition system. This new 
theory, the BIS/BAS model of chronic pain, proposes that pain is experienced as an 
aversive or negative stimulus and therefore activates the inhibition system (Eccleston & 
Crombez, 1999; Jensen et al., 2016). This, in turn, may cause avoidance behaviour and 
could lead to anxiety and catastrophising (Jensen et al., 2016; Lucchetti, Oliveira, 
Mercante, & Peres, 2012). When individuals are in an anxious state, there is an increased 
tendency to focus on threat-related cues, and decreased tendency to disengage from those 
threat-related cues. In the presence of cues that signal pain, ‘safety cues’ receive less 
attention. It is in this way that pain can have an inhibitory effect on activation behaviours. 
In the presence or anticipation of pain, a decrease in BAS could be expected, because BIS 
has some inhibitory effect on BAS. It is further argued that when a painful stimulus is 
removed, a positive feeling of relief typically ensues and this triggers the activation system 
(Jensen et al., 2016). However, in people suffering from chronic pain, reward circuits in the 
brain can function be disrupted (Elvemo, Landrø, Borchgrevink, & Haberg, 2015). 
 
The proposed BIS-BAS model of chronic pain builds on the Fear-Avoidance Model of 
pain. Jensen and colleagues (2016) argued that, while they could appreciate the mutual 
causation of pain relating to disability, avoidance beliefs, kinesiophobia, in a disuse cycle, 
they preferred a multidirectional over a unidirectional model, such as the Fear-Avoidance 
model. Thus, the BIS-BAS model of chronic pain is structured like a web, with more focus 
on an interactional perspective. The model proposes that there is more interaction between 
variables that cause, contribute to and result from the pain experience, such as 
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environmental cues, a person's emotional state or affect (including proneness to anxiety or 
depression) and cognitive cues (such as learnt behaviour that pain is dangerous, or 
conversely that pain will be short lived and therefore expecting relief). Furthermore, this 
model suggests that these variables are interchangeable as both mechanisms and outcomes. 
As an example, this model allows for anxiety to be 1) a personality trait that worsens an 
individual’s perception of their pain, 2) a symptom that is brought on as a result of pain, or 
3) symptom that develops through the irresolution of pain affecting daily life.  
 
Jensen et al. (2016) further argue that individuals whose primary response is that of 
activation may respond to a greater degree to a specific set of intervention approaches and 
that this differs from individuals whose primary response is that of inhibition. Patients who 
are characterised by predominant activation responses may adopt an active coping strategy, 
but in their bid to overcome their pain may tend to overact and re-aggravate the painful 
area. Here, most effective treatment approaches could include behavioural moderation and 
cognitive therapy (Jensen et al., 2016). Primarily inhibitive individuals may be more likely 
to interpret sensations as painful, be more fearful in general and more prone to 
catastrophising, thus fitting into a fear-avoidance model of (chronic) pain (Crombez et al., 
2012; Jensen et al., 2016). Educational approaches aimed at diminishing anxiety around 
pain may be best suited to these individuals.  
 
Sub-grouping individuals affected by pain based on their levels of activation and inhibition 
could, therefore, facilitate the allocation of more effective management strategies. Such a 
person-centric approach to patient management has been shown to be effective in reducing 
time and money spent in therapy and time off work, and is likely to promote a positive 
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patient experience of treatment (Bradbury et al., 2013; Constand et al., 2014; Paul-Savoie, 
Bourgault, Gosselin, Potvin, & Lafrenaye, 2015). 
 
Previous Studies  
At present, very little literature has examined a putative relationship between activation and 
inhibition systems and pain perception. Jensen et al.'s (2015) study was based on a large 
asymptomatic sample (n=563). The university sample was also relatively homogeneous 
regarding background and relatively young (average age 19). Jensen et al. (2015) included 
a standard scale assessing levels of inhibition and activation (BIS/BAS Scale, Carver & 
White, 1994), an assessment of the frequency of headaches, and a question relating to 
participants’ average pain intensity at ten main body areas. Results showed a significant 
relationship between activation of the inhibition system and pain intensity and headache 
frequency.  
 
A fundamental limitation of the study by Jensen et al. (2015) was the young, asymptomatic 
sample population. First, generalisation to typical (chronic) pain populations from this 
sample is difficult, as the participants were not suffering chronic pain. Second, it has been 
shown that the scale used to assess levels of inhibition and activation (BIS/BAS Scale, 
Carver & White, 1994),  is most consistent for age ranges beyond that of the Jensen et al. 
(2015) sample (Jorm et al., 1998). Third, sampling an asymptomatic population resulted in 
a broad and uneven distribution of pain sites. This resulted in limited power for statistical 
analyses. Instead, headache frequency was analysed, which is again not easily generalised 
to people with musculoskeletal pain as the cause of headaches can be widely varied (Stark 
et al., 2013). A final limitation of the study relates to the use of non-standardised 
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questionnaires for the assessment of pain site and duration of headaches. Replicability and 
comparability with other findings in the literature are limited as a result.  
 
A second, more recent study by Jensen et al. (2017) built on their above-discussed work 
and aimed to assess pain intensity and behavioural inhibition in a chronic pain population 
(n=88). Kinesiophobia, catastrophising, pain interference, and depressive symptoms were 
also assessed. Hierarchical linear regressions gave interesting results about the relationships 
between behavioural inhibition and mal-adaptive cognitions. A significant effect of high 
behavioural inhibition on depressive symptoms was revealed after pain intensity was 
controlled for, as well as a moderating effect of behavioural inhibition on the relationship 
between kinesiophobia and depressive symptoms. There were no significant results 
pertaining to the relationship between behavioural inhibition and pain intensity directly, nor 
behavioural inhibition and kinesiophobia directly. The small sample size is a limitation of 
this second study. Having a small sample can negatively impact statistical reliability (Field, 
2009). Also, the authors of this study state that the cross-sectional design was a limitation 
of this study (Jensen et al., 2017).  
 
Both these studies used the BIS/BAS Scale to assess for behavioural inhibition and 
activation. This questionnaire appears to have uneven weighting between items assessing 
inhibition and activation, with three subscales reflecting different aspects of the activation 
system: Drive, Fun Seeking and Reward Responsiveness, and only one for behavioural 
inhibition. Despite this flaw, the BIS/BAS Scale is the most widely used measure for the 
Reinforcement Sensitivity Theory constructs of behavioural inhibition and activation (Corr, 
2016). The BIS/BAS Scale has been found to be a valid and reliable tool, with all four 
subscales having internal consistencies ranging from .66 to .76, and test-retest reliabilities 
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of  .59 to .69 (Carver & White, 1994a; Cogswell, Alloy, van Dulmen, & Fresco, 2006). The 
second most popular instrument assessing these factors is the Sensitivity to Punishment and 
Sensitivity to Reward Questionnaire (SPSRQ) (Torrubia, Ávila, Moltó, & Caseras, 2001). 
Though still popular, it has been less widely used due to having only one factor each for 
behavioural inhibition and behavioural activation; the latter is now generally recognised to 
be multidimensional. Additionally, there are 48 items, compared to 24 for the BIS/BAS 
Scale, making it comparatively more arduous for participants to complete (Corr, 2016). A 
primary flaw of both of these instruments, particularly when utilised in studies examining 
behaviour and pain, is that neither includes items assessing pain or response to pain 
specifically (Jensen, Ward, Thorn, Ehde, & Day, 2017).  
 
Presently, Jensen and colleagues (2017) are exploring the design of a tool to specifically 
examine behavioural pain response. This new instrument, while based on the behavioural 
activation and inhibition systems, assesses cognition and beliefs, emotion and behavioural 
intentions in relation to pain. The two subscales are therefore likely to be named Negative 
Responsivity to Pain and Positive Responsivity scales (Jensen et al., 2017). On initial 
assessment, these scales appear to demonstrate moderately strong psychometric properties, 
and clinical utility, with only 20 items in total. However, the authors state that further 
amendment and testing to the items within the Negative Responsivity subscale is 
warranted. Also, further research into the Positive Responsivity scale as a whole is 
recommended before this instrument is made available for use (Jensen et al., 2017). 
 
Alongside further examination of the negative and positive responsivity to pain constructs, 
future research could also expand on the BIS/BAS model of chronic pain. Structural 
equation modelling should be considered, with a view to providing more detail about 
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weighting and causal aspects of the proposed relationships in the BIS-BAS theory of 
chronic pain.  
 
Conclusion 
Healthcare sectors worldwide appear to be leaning toward assessing and treating pain 
through a much more holistic biopsychosocial approach. Despite this, the incidence, 
prevalence and associated cost of pain-related complaints continue to rise. Multimodal 
interventions are showing the most promising results in pain management. The new theory 
of innate behavioural tendencies lends a fascinating new angle to a biopsychosocial 
approach, with specific treatment options outlined for individuals that tend toward 
inhibitory or approach behaviours. This theory has so far shown promising results in 
relating pain experience with these behavioural tendencies, although further study in a 
larger population of adults complaining of musculoskeletal pain is required. Future research 
could also expand on the scale to measure behavioural traits by tailoring the questions to 
pain experience.  
 
  
 33 
References 
Aaseth, K., Grande, R. B., Kværner, K. J., Gulbrandsen, P., Lundqvist, C., & Russell, M. B. 
(2008). Prevalence of secondary chronic headaches in a population-based sample of 
30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia, 28(7), 
705–713. http://doi.org/10.1111/j.1468-2982.2008.01577.x 
ACC. (2004). New Zealand Acute Low Back Pain Guide. Wellington. Retrieved from 
https://www.healthnavigator.org.nz/media/1006/nz-acute-low-back-pain-guide-acc.pdf 
ACC. (2016). Injury statistics tool. Retrieved from http://www.acc.co.nz/about-
acc/statistics/injury-statistics-tool/index.htm 
ACC. (2017). Statistics on our claims. Retrieved October 31, 2017, from 
https://www.acc.co.nz/about-us/statistics/ 
Access Economics. (2007). The high price of pain: the economic impact of persistent pain 
in Australia. Sydney. 
Apkarian, A. V, Hashmi, J. A., & Baliki, M. N. (2012). Pain and the brain: Specificity and 
plasticity of the brain in clinical chronic pain. Pain, 152, 1–35. 
http://doi.org/10.1016/j.pain.2010.11.010.Pain 
Arnstein, P., Caudill, M., Mandle, C. L., Norris, A., & Beasley, R. (1999). Self efficacy as 
a mediator of the relationship between pain intensity, disability and depression in 
chronic pain patients. Pain, 80(3), 483–491. http://doi.org/10.1016/S0304-
3959(98)00220-6 
Balconi, M., Falbo, L., & Conte, V. A. (2011). BIS and BAS correlates with 
psychophysiological and cortical response systems during aversive and appetitive 
emotional stimuli processing. Motivation and Emotion, 36(2), 218–231. 
http://doi.org/10.1007/s11031-011-9244-7 
Balleine, B. W., & Killcross, S. (2006). Parallel incentive processing: an integrated view of 
 34 
amygdala function. Trends in Neurosciences, 29(5), 272–279. 
http://doi.org/10.1016/j.tins.2006.03.002 
Beck, A. T. (1963). Thinking and Depression. Archives of General Psychiatry, 10(6), 561–
571. http://doi.org/10.1001/archpsyc.1964.01720240015003 
Beck, A. T., & Dozois, D. J. A. (2011). Cognitive Therapy: Current Status and Future 
Directions. Annual Review of Medicine, 62(1), 397–409. 
http://doi.org/10.1146/annurev-med-052209-100032 
Becker, S., Gandhi, W., & Schweinhardt, P. (2012). Cerebral interactions of pain and 
reward and their relevance for chronic pain. Neuroscience Letters, 520(2), 182–187. 
http://doi.org/10.1016/j.neulet.2012.03.013 
Bendelow, G. (2013). Medicine and Society: Chronic Pain Patients and the Biomedical 
Model of Pain. American Medical Association Journal of Ethics, 15(5), 455–459. 
http://doi.org/10.1001/virtualmentor.2013.15.5.msoc1-1305 
Bogduk, N. (1999). Evidence-based clinical guidelines for the management of acute low 
back pain, (November), 1–121. 
Bradbury, K. J., Bishop, F. L., Yardley, L., & Lewith, G. (2013). Patients’ appraisals of 
public and private healthcare: a qualitative study of physiotherapy and osteopathy. 
Journal of Health Psychology, 18(10), 1307–18. 
http://doi.org/10.1177/1359105312465101 
Brooks, J., McCluskey, S., King, N., & Burton, K. (2013). Illness perceptions in the context 
of differing work participation outcomes: Exploring the influence of significant others 
in persistent back pain. BMC Musculoskeletal Disorders, 14. 
http://doi.org/10.1186/1471-2474-14-48 
Brown, J. L., Sheffield, D., Leary, M. R., & Robinson, M. E. (2003). Social support and 
experimental pain. Psychosomatic Medicine, 65(2), 276–283. 
 35 
http://doi.org/10.1097/01.PSY.0000030388.62434.46 
Brox, J. I. (2014). Current evidence on catastrophizing and fear avoidance beliefs in low 
back pain patients. The Spine Journal, 14(11), 2679–2681. 
http://doi.org/10.1016/j.spinee.2014.08.454 
Burke, A. L. J., Mathias, J. L., & Denson, L. A. (2015). Psychological functioning of 
people living with chronic pain: A meta-analytic review. British Journal of Clinical 
Psychology, 54(3), 345–360. http://doi.org/10.1111/bjc.12078 
Burton, A. K., Balagué, F., Cardon, G., Eriksen, H. R., Hänninen, O., Harvey, E., … van 
der Beek, A. (2005, August 1). How to prevent low back pain. Best Practice and 
Research: Clinical Rheumatology. Elsevier. http://doi.org/10.1016/j.berh.2005.03.001 
Butler, D. S., & Moseley, G. L. (2003). Explain Pain. Adelaide: Noigroup publications. 
Campbell-Sills, L., Liverant, G. I., & Brown, T. A. (2004). Psychometric Evaluation of the 
Behavioral Inhibition/Behavioral Activation Scales in a Large Sample of Outpatients 
With Anxiety and Mood Disorders. Psychological Assessment, 16(3), 244–254. 
Carver, C. S., & White, T. L. (1994a). Behavioral inhibition, behavioral activation, and 
affective responses to impending reward and punishment: The BIS/BAS Scales. 
Journal of Personality and Social Psychology, 67, 319–333. 
Carver, C. S., & White, T. L. (1994b). BIS/BAS scales. Retrieved from 
http://www.psy.miami.edu/faculty/ccarver/sclBISBAS.html 
Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., … Deyo, 
R. A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: 
A systematic review for a national institutes of health pathways to prevention 
workshop. Annals of Internal Medicine, 162(4), 276–286. http://doi.org/10.7326/M14-
2559 
Cogswell, A., Alloy, L. B., van Dulmen, M. H. M., & Fresco, D. M. (2006). A 
 36 
psychometric evaluation of behavioral inhibition and approach self-report measures. 
Personality and Individual Differences, 40(8), 1649–1658. 
http://doi.org/10.1016/j.paid.2005.12.008 
Constand, M. K., MacDermid, J. C., Dal Bello-Haas, V., Law, M., Mead, N., Bower, P., … 
Freeman, R. (2014). Scoping review of patient-centered care approaches in healthcare. 
BMC Health Services Research, 14(1), 271. http://doi.org/10.1186/1472-6963-14-271 
Corr, P. (2013). Approach and Avoidance Behaviour: Multiple Systems and their 
Interactions. Emotion Review, 5(3), 285–290. 
http://doi.org/10.1177/1754073913477507 
Corr, P. J. (2016). Reinforcement Sensitivity Theory of Personality Questionnaires: 
Structural survey with recommendations. Personality and Individual Differences, 89, 
60–64. http://doi.org/10.1016/j.paid.2015.09.045 
Crombez, G., Eccleston, C., Damme, S. Van, Vlaeyen, J. W. S., & Karoly, P. (2012). The 
fear avoidance model of chronic pain: the next generation. The Clinical Journal of 
Pain, 28, 475–483. http://doi.org/10.1097/AJP.0b013e3182385392 
Crombez, G., Vlaeyen, J. W. S., Heuts, P. H. T. G., & Lysens, R. (1999). Pain-related fear 
is more disabling than pain itself: Evidence on the role of pain-related fear in chronic 
back pain disability. Pain, 80(1–2), 329–339. http://doi.org/10.1016/S0304-
3959(98)00229-2 
Darlow, B. (2016). Beliefs about back pain: the confluence of client, clinician and 
community. International Journal of Osteopathic Medicine. 
http://doi.org/10.1016/j.ijosm.2016.01.005 
Darlow, B., Perry, M., Stanley, J., Mathieson, F., Melloh, M., Baxter, G. D., & Dowell, A. 
(2014). Cross-sectional survey of attitudes and beliefs about back pain in New 
Zealand. BMJ Open, 4(5), e004725. http://doi.org/10.1136/bmjopen-2013-004725 
 37 
Das, V. (2015). An Introduction to Pain Pathways and Pain “Targets.” Progress in 
Molecular Biology and Translational Science, 131, 1–30. 
http://doi.org/10.12968/hmed.2013.74.Sup12.C188 
Day, M., & Thorn, B. (2010). The relationship of demographic and psychosocial variables 
to pain-related outcomes in a rural chronic pain population. Pain, 151(2), 467–474. 
http://doi.org/10.1016/j.pain.2010.08.015 
de Vos Andersen, N.-B., Kent, P., Hjort, J., & Christiansen, D. H. (2017). Clinical Course 
and Prognosis of Musculoskeletal Pain in Patients Referred for Physiotherapy: Does 
Pain Site Matter? BMC Mu, 18(130). http://doi.org/10.2522/ptj.20100192 
Demianczyk, A., Jenkins, A., Henson, J., & Conner, B. (2014). Psychometric Evaluation 
and Revision of Carver and White’s BIS/BAS Scales in a Diverse Sample of Young 
Adults. Journal of Personality Assessment, 96(5), 485–494. 
Denison, E., Åsenlöf, P., & Lindberg, P. (2004). Self-efficacy, fear avoidance, and pain 
intensity as predictors of disability in subacute and chronic musculoskeletal pain 
patients in primary health care. Pain, 111(3), 245–252. 
http://doi.org/10.1016/j.pain.2004.07.001 
Driscoll, T., Jacklyn, G., Orchard, J., Passmore, E., Vos, T., Freedman, G., … Punnett, L. 
(2014). The global burden of occupationally related low back pain: Estimates from the 
Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases, 73(6), 975–
981. http://doi.org/10.1136/annrheumdis-2013-204631 
Dubin, A. E., & Patapoutian, A. (2010). Nociceptors: the sensors of the pain pathway. The 
Journal of Clinical Investigation, 120(11). http://doi.org/10.1172/JCI42843.3760 
Dunn, K. M., Jordan, K. P., Mancl, L., Drangsholt, M. T., & Le Resche, L. (2011). 
Trajectories of pain in adolescents: A prospective cohort study. Pain, 152(1), 66–73. 
http://doi.org/10.1016/j.pain.2010.09.006 
 38 
Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. 
P., … Witter, J. (2005). Core outcome measures for chronic pain clinical trials: 
IMMPACT recommendations. Pain, 113(1–2), 9–19. 
http://doi.org/10.1016/j.pain.2004.09.012 
Eccleston, C., & Crombez, G. (1999). Pain demands attention: A cognitive–affective model 
of the interruptive function of pain. Psychological Bulletin, 125(3), 356–366. 
Eccleston, C., Morley, S. J., & Williams, A. C. (2013). Psychological approaches to 
chronic pain management: Evidence and challenges. British Journal of Anaesthesia, 
111(1), 59–63. http://doi.org/10.1093/bja/aet207 
Ehde, D. M., Dillworth, T. M., & Turner, J. A. (2014). Cognitive-behavioral therapy for 
individuals with chronic pain: Efficacy, innovations, and directions for research. 
American Psychologist, 69(2), 153–166. http://doi.org/10.1037/a0035747 
Elvemo, N. A., Landrø, N. I., Borchgrevink, P. C., & Haberg, A. K. (2015). Reward 
responsiveness in patients with chronic pain. European Journal of Pain, 19(10), 1537–
1543. http://doi.org/10.1002/ejp.687 
Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. 
Science, 196(4286), 129–136. http://doi.org/10.1126/science.139.3550.81 
Engel, G. L. (1980). The clinical application of the biopsychosocial model. The American 
Journal of Psychiatry, 137(5), 535–544. http://doi.org/10.1176/ajp.137.5.535 
Fayaz, A., Croft, P., Langford, R. M., Donaldson, L. J., & Jones, G. T. (2016). Prevalence 
of chronic pain in the UK: A systematic review and meta-analysis of population 
studies. BMJ Open, 6(6). http://doi.org/10.1136/bmjopen-2015-010364 
Field, A. (2009). Discovering Statistics Using SPSS (3rd ed.). London: SAGE Publications. 
http://doi.org/10.1111/insr.12011_21 
Fredin, K., & Lorås, H. (2017). Manual therapy, exercise therapy or combined treatment in 
 39 
the management of adult neck pain – A systematic review and meta-analysis. 
Musculoskeletal Science and Practice, 31, 62–71. 
http://doi.org/10.1016/j.msksp.2017.07.005 
Froud, R., Patterson, S., Eldridge, S., Seale, C., Pincus, T., Rajendran, D., … Underwood, 
M. (2014). A systematic review and meta-synthesis of the impact of low back pain on 
people’s lives. BMC Musculoskeletal Disorders, 15(1), 50. 
http://doi.org/10.1186/1471-2474-15-50 
Fryer, G., Alvizatos, J., & Lamaro, J. (2005). The effect of osteopathic treatment on people 
with chronic and sub-chronic neck pain : A pilot study. International Journal of 
Osteopathic Medicine, 8. http://doi.org/10.1016/j.ijosm.2005.03.001 
Gaskin, D. J., & Richard, P. (2012). The Economic Costs of Pain in the United States. The 
Journal of Pain, 13(8), 715–724. http://doi.org/10.1016/j.jpain.2012.03.009 
Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N., & Turk, D. C. (2007). The 
Biopsychosocial Approach to Chronic Pain: Scientific Advances and Future 
Directions. Psychological Bulletin, 133(4), 581–624. http://doi.org/10.1037/0033-
2909.133.4.581 
Gatzounis, R., Schrooten, M. G. S., Crombez, G., & Vlaeyen, J. W. S. (2014). Interrupted 
by pain: An anatomy of pain-contingent activity interruptions. Pain, 155(7), 1192–
1195. http://doi.org/10.1016/j.pain.2014.03.017 
Gebhart, G. F., Basbaum, A. I., Bird, S. J., Flecknell, P., Goodly, L., Karas, A. Z., … 
Soriano, S. G. (2009). Recognition and Alleviation of Pain in Laboratory Animals. 
Laboratory Animals (Vol. 44). http://doi.org/10.1258/la.2010.201003 
Gelman, A., & Park, D. K. (2009). Splitting a Predictor at the Upper Quarter or Third and 
the Lower Quarter or Third. The American Statistician, 63(1), 1–8. 
http://doi.org/10.1198/tast.2009.0001 
 40 
George, S. Z., Valencia, C., & Beneciuk, J. M. (2010). A psychometric investigation of 
fear-avoidance model measures in patients with chronic low back pain. The Journal of 
Orthopaedic and Sports Physical Therapy, 40(4), 197–205. 
http://doi.org/10.2519/jospt.2010.3298 
Giesecke, T., Gracely, R. H., Grant, M. A. B., Nachemson, A., Petzke, F., Williams, D. A., 
& Clauw, D. J. (2004). Evidence of augmented central pain processing in idiopathic 
chronic low back pain. Arthritis & Rheumatism, 50(2), 613–623. 
http://doi.org/10.1002/art.20063 
Gotink, R. A., Chu, P., Busschbach, J. J. V., Benson, H., Fricchione, G. L., & Hunink, M. 
G. M. (2015). Standardised mindfulness-based interventions in healthcare: An 
overview of systematic reviews and meta-analyses of RCTs. PLoS ONE, 10(4), 1–17. 
http://doi.org/10.1371/journal.pone.0124344 
Gray, J. A. (1970). The psychophysiological basis of introversion-extraversion. Behaviour 
Research and Therapy, 8(3), 249–266. http://doi.org/10.1016/0005-7967(70)90069-0 
Gray, J. A. (1990). Brain Systems that Mediate both Emotion and Cognition. Cognition & 
Emotion, 4(3), 269–288. http://doi.org/10.1080/02699939008410799 
Gray, J. A., & McNaughton, N. (2000). The Neuropsychology of Anxiety: An Enquiry into 
the Functions of the Septo-Hippocampal System, Second Edition. (N. Mackintosh, T. 
Shallice, A. Treisman, J. McGaugh, D. Schacter, & L. Weiskrantz, Eds.) (2nd ed.). 
Oxford: Oxford University Press. Retrieved from http://stoa.usp.br/vahs/files/-
1/16169/Gray+e+McNaughton+-+Neuropsychology+of+Anxiety.pdf 
Gray, J. D., Hanna, D., Gillen, A., & Rushe, T. (2016). A closer look at Carver and White’s 
BIS/BAS scales: Factor analysis and age group differences. Personality and Individual 
Differences, 95, 20–24. http://doi.org/10.1016/j.paid.2016.02.022 
Gray, & McNaughton, N. (2000). The Neuropsychology of Anxiety: An Enquiry into the 
 41 
Functions of the Septo-Hippocampal System, Second Edition. (N. Mackintosh, T. 
Shallice, A. Treisman, J. McGaugh, D. Schacter, & L. Weiskrantz, Eds.) (2nd ed.). 
Oxford: Oxford University Press. Retrieved from http://stoa.usp.br/vahs/files/-
1/16169/Gray+e+McNaughton+-+Neuropsychology+of+Anxiety.pdf 
Grichnik, K. P., & Ferrante, F. M. (1991). The difference between acute and chronic pain. 
The Mount Sinai Journal of Medicine, NY, 58(3), 217–20. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/1875958 
Grönblad, M., Hupli, M., Wennerstrand, P., Järvinen, E., Lukinmaa, A., Kouri, J. P., & 
Karaharju, E. O. (1993). Intercorrelation and test-retest reliability of the Pain 
Disability Index (PDI) and the Oswestry Disability Questionnaire (ODQ) and their 
correlation with pain intensity in low back pain patients. The Clinical Journal of Pain. 
http://doi.org/10.1097/00002508-199309000-00006 
Gross, D. P., Ferrari, R., Russell, A. S., Battié, M. C., Schopflocher, D., Hu, R. W., … 
Buchbinder, R. (2006). A population-based survey of back pain beliefs in Canada. 
Spine, 31(18), 2142–2145. http://doi.org/10.1097/01.brs.0000231771.14965.e4 
Hartvigsen, J., Nielsen, J., Kyvik, K. O. H. M., Fejer, R., Vach, W., Iachine, I., & Leboeuf-
Yde, C. (2009). Heritability of spinal pain and consequences of spinal pain: A 
comprehensive genetic epidemiologic analysis using a population-based sample of 
15,328 twins ages 20-71 years. Arthritis Care and Research, 61(10), 1343–1351. 
http://doi.org/10.1002/art.24607 
Hawker, G. A., Mian, S., Kendzerska, T., & French, M. (2011). Measures of adult pain: 
Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), 
McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-
MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF. 
Arthritis Care and Research, 63(11), 240–252. http://doi.org/10.1002/acr.20543 
 42 
Henschke, N., Kamper, S. J., & Maher, C. G. (2015). The epidemiology and economic 
consequences of pain. Mayo Clinic Proceedings, 90(1), 139–147. 
http://doi.org/10.1016/j.mayocp.2014.09.010 
Herr, K. A., & Garand, L. (2001). Assessment and measurement of pain in older adults. 
Clinics in Geriatric Medicine, 17(3), 457–78, vi. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11459715 
Hidalgo, B., Detrembleur, C., Hall, T., Mahaudens, P., & Nielens, H. (2014). The efficacy 
of manual therapy and exercise for different stages of non-specific low back pain : an 
update of systematic reviews. Journal of Manual and Manipulative Therapy, 22(2), 
59–74. http://doi.org/10.1179/2042618613Y.0000000041 
Hill, J. C., Whitehurst, D. G. T., Lewis, M., Bryan, S., Dunn, K. M., Foster, N. E., … Hay, 
E. M. (2011). Comparison of stratified primary care management for low back pain 
with current best practice (STarT Back): A randomised controlled trial. The Lancet, 
378(9802), 1560–1571. http://doi.org/10.1016/S0140-6736(11)60937-9 
Ho, P., & Johnson, M. H. (2013). Behaviours and beliefs about pain and treatment among 
Chinese immigrants and New Zealand Europeans. Journal of the New Zealand 
Medical Association, 126(1370). 
Hobara, M. (2005). Beliefs about appropriate pain behavior: Cross-cultural and sex 
differences between Japanese and Euro-Americans. European Journal of Pain, 9(4), 
389–393. http://doi.org/10.1016/j.ejpain.2004.09.006 
Holt-Lunstad, J., Smith, T. B., & Layton, J. B. (2010). Social relationships and mortality 
risk: A meta-analytic review. PLoS Medicine, 7(7). 
http://doi.org/10.1371/journal.pmed.1000316 
Hoy, D., Bain, C., Williams, G., March, L., Brooks, P., Blyth, F., … Buchbinder, R. 
(2012). A systematic review of the global prevalence of low back pain. Arthritis & 
 43 
Rheumatism, 64(6), 2028–2037. http://doi.org/10.1002/art.34347 
Hoy, D., Brooks, P., Blyth, F., & Buchbinder, R. (2010). The Epidemiology of low back 
pain. Best Practice and Research: Clinical Rheumatology, 24(6), 769–781. 
http://doi.org/10.1016/j.berh.2010.10.002 
Ihlebæk, C., & Eriksen, H. R. (2003). Are the “myths” of low back pain alive in the general 
Norwegian population? Scandinavian Journal of Public Health, 31(5), 395–398. 
http://doi.org/10.1080/14034940210165163 
Jensen, M. P., Ehde, D. M., & Day, M. A. (2016). The Behavioral Activation and Inhibition 
Systems: Implications for Understanding and Treating Chronic Pain. The Journal of 
Pain, 17(5), 50–52. http://doi.org/10.1016/j.jpain.2016.02.001 
Jensen, M. P., Solé, E., Castarlenas, E., Racine, M., Roy, R., Miró, J., & Cane, D. (2017). 
Behavioral inhibition, maladaptive pain cognitions, and function in patients with 
chronic pain. Scandinavian Journal of Pain, 17, 41–48. 
http://doi.org/10.1016/j.sjpain.2017.07.002 
Jensen, M. P., Tan, G., & Chua, S. M. (2015). Pain Intensity, Headache Frequency, and the 
Behavioral Activation and Inhibition Systems. The Clinical Journal of Pain, 31(12), 
1068–1074. http://doi.org/10.1097/AJP.0000000000000215 
Jensen, M. P., Ward, L. C., Thorn, B. E., Ehde, D. M., & Day, M. A. (2017). Measuring the 
Cognitions, Emotions, and Motivation Associated with Avoidance Behaviors in the 
Context of Pain. The Clinical Journal of Pain, 33(4), 325–334. 
http://doi.org/10.1097/AJP.0000000000000407 
Jensen, Tan, G., & Chua, S. M. (2015). Pain Intensity, Headache Frequency, and the 
Behavioral Activation and Inhibition Systems. The Clinical Journal of Pain, 31(12), 
1068–1074. http://doi.org/10.1097/AJP.0000000000000215 
Ji, R.-R., Xu, Z.-Z., & Gao, Y.-J. (2014). Emerging targets in neuroinflammation-driven 
 44 
chronic pain. Nature Reviews Drug Discovery, 13(7), 533–548. 
http://doi.org/10.1038/nrd4334 
Jorm, A. ., Christensen, H., Henderson, A. ., Jacomb, P. ., Korten, A. ., & Rodgers, B. 
(1998). Using the BIS/BAS scales to measure behavioural inhibition and behavioural 
activation: Factor structure, validity and norms in a large community sample. 
Personality and Individual Differences, 26(1), 49–58. http://doi.org/10.1016/S0191-
8869(98)00143-3 
Jorm, A., Christensen, H., Henderson, A. S., Jacomb, P., Korten, A. E., & Rodgers, B. 
(1998). Using the BIS/BAS scales to measure behavioural inhibition and behavioural 
activation: Factor structure, validity and norms in a large community sample. 
Personality and Individual Differences, 26(1), 49–58. http://doi.org/10.1016/S0191-
8869(98)00143-3 
Keeffe, M. O., Purtill, H., Kennedy, N., Conneely, M., Hurley, J., Sullivan, P. O., … 
Sullivan, K. O. (2016). Comparative Effectiveness of Conservative Interventions for 
Nonspecific Chronic Spinal Pain: Physical, Behavioral/Psychologically Informed, or 
Combined? A Systematic Review and Meta-Analysis. The Journal of Pain, 17(7), 
755–774. http://doi.org/10.1016/j.jpain.2016.01.473 
Kennis, M., Rademaker, A. R., & Geuze, E. (2013). Neural correlates of personality: an 
integrative review. Neuroscience and Biobehavioral Reviews, 37(1), 73–95. 
http://doi.org/10.1016/j.neubiorev.2012.10.012 
Krahé, C., Springer, A., Weinman, J. A., & Fotopoulou, A. (2013). The Social Modulation 
of Pain: Others as Predictive Signals of Salience – a Systematic Review. Frontiers in 
Human Neuroscience, 7(July), 1–21. http://doi.org/10.3389/fnhum.2013.00386 
Latremoliere, A., & Woolf, C. (2009). Central Sensitization: a generator of pain 
hypersensitivity by Central Neural Plasticity. Pain, 10(9), 895–926. 
 45 
http://doi.org/10.1016/j.jpain.2009.06.012.Central 
Lee, H., Hübscher, M., Moseley, G. L., Kamper, S. J., Traeger, A. C., Mansell, G., & 
McAuley, J. H. (2015). How does pain lead to disability? A systematic review and 
meta-analysis of mediation studies in people with back and neck pain. Pain, 156(6), 
988–97. http://doi.org/10.1097/j.pain.0000000000000146 
Lee, J. E., Kahana, B., & Kahana, E. (2016). Social Support and Cognitive Functioning as 
Resources for Elderly Persons with Chronic Arthritis Pain. Aging Mental Health, 
20(4), 370–379. http://doi.org/10.1080/13607863.2015.1013920 
Leeuw, M., Goossens, M. E. J. B., Linton, S. J., Crombez, G., Boersma, K., & Vlaeyen, J. 
W. S. (2007). The fear-avoidance model of musculoskeletal pain: Current state of 
scientific evidence. Journal of Behavioral Medicine, 30(1), 77–94. 
http://doi.org/10.1007/s10865-006-9085-0 
Levy, B., Paulozzi, L., Mack, K. A., & Jones, C. M. (2015). Trends in Opioid Analgesic–
Prescribing Rates by Specialty, U.S., 2007–2012. American Journal of Preventive 
Medicine, 49(3), 409–413. http://doi.org/10.1016/j.amepre.2015.02.020 
Licciardone, J. C., Brimhall, A. K., & King, L. N. (2005). Osteopathic manipulative 
treatment for low back pain: a systematic review and meta-analysis of randomized 
controlled trials. BMC Musculoskeletal Disorders, 6(1), 43. 
http://doi.org/10.1186/1471-2474-6-43 
Louw, A., Diener, I., Butler, D. S., & Puentedura, E. J. (2011). The effect of neuroscience 
education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. 
Archives of Physical Medicine and Rehabilitation, 92(12), 2041–2056. 
http://doi.org/10.1016/j.apmr.2011.07.198 
Lucchetti, G., Oliveira, A. B., Mercante, J. P. P., & Peres, M. F. P. (2012). Anxiety and 
Fear-Avoidance in Musculoskeletal Pain. Current Pain and Headache Reports, 16(5), 
 46 
399–406. http://doi.org/10.1007/s11916-012-0286-7 
Machado, G. C., Maher, C. G., Ferreira, P. H., Day, R. O., Pinheiro, M. B., & Ferreira, M. 
L. (2017). Non-steroidal anti-inflammatory drugs for spinal pain: A systematic review 
and meta-analysis. Annals of the Rheumatic Diseases, 76(7), 1269–1278. 
http://doi.org/10.1136/annrheumdis-2016-210597 
Machado, G. C., Maher, C. G., Ferreira, P. H., Pinheiro, M. B., Lin, C.-W. C., Day, R. O., 
… Ferreira, M. L. (2015). Efficacy and safety of paracetamol for spinal pain and 
osteoarthritis: systematic review and meta-analysis of randomised placebo controlled 
trials. BMJ, 350. http://doi.org/10.1136/bmj.h1225 
Magnusson, J., & Fennel, J. (2011). Understanding the role of culture in pain: Māori 
practitioner perspectives relating to the experience of pain. Journal of the New 
Zealand Medical Association, 124(1328), 41–51. 
Mallen, C. D., Peat, G., Thomas, E., Dunn, K. M., & Croft, P. R. (2007). Prognostic factors 
for musculoskeletal pain in primary care: a systematic review. British Journal of 
General Practice, 57(541), 655–661. http://doi.org/10.1136/bmjopen-2016-012901 
Mansfield, K. E., Sim, J., Jordan, J. L., & Jordan, K. P. (2016). A systematic review and 
meta-analysis of the prevalence of chronic widespread pain in the general population. 
Pain, 157(1), 55–64. http://doi.org/10.1097/j.pain.0000000000000314 
Margolis, R. B., Tait, R. C., & Krause, S. J. (1986). A rating system for use with patient 
pain drawings. Pain, 24(1), 57–65. http://doi.org/10.1016/0304-3959(86)90026-6 
McNaughton, N., & Corr, P. J. (2004). A two-dimensional neuropsychology of defense: 
fear/anxiety and defensive distance. Neuroscience and Biobehavioral Reviews, 28(3), 
285–305. http://doi.org/10.1016/j.neubiorev.2004.03.005 
Melzack, R., & Wall, P. (1965). Pain Mechanism: A new Theory. Science. 
http://doi.org/10.1126/science.150.3699.971 
 47 
Merskey, H., & Bogduk, N. (1994). Classification of Chronic Pain. IASP Pain 
Terminology. http://doi.org/10.1002/ana.20394 
Miller, Kori, & Todd. (1995). Tampa Scale for Kinesiophobia ( TSK ). Pain. 
Miranda, H., Kaila-Kangas, L., Heliövaara, M., Leino-Arjas, P., Haukka, E., Liira, J., & 
Viikari-Juntura, E. (2010). Musculoskeletal pain at multiple sites and its effects on 
work ability in a general working population. Occupational and Environmental 
Medicine, 67(7), 449–455. http://doi.org/10.1136/oem.2009.048249 
Mogil, J. S. (2012). Pain genetics: Past, present and future. Trends in Genetics, 28(6), 258–
266. http://doi.org/10.1016/j.tig.2012.02.004 
Moseley, G. L. (2007). Reconceptualising pain according to modern pain science. Physical 
Therapy Reviews, 12(3), 169–178. http://doi.org/10.1179/108331907X223010 
Moseley, G. L., & Butler, D. S. (2015). Fifteen Years of Explaining Pain: The Past, 
Present, and Future. The Journal of Pain, 16(9), 807–813. 
http://doi.org/10.1016/j.jpain.2015.05.005 
Moskowitz, M., & Golden, M. (2013). Neuroplastic Transformation: Your Brain on Pain. 
Munigangaiah, S., Basavaraju, N., Jadaan, D. Y., Devitt, A. T., & McCabe, J. P. (2016). Do 
“Myths” of low back pain exist among Irish population? A cross-sectional study. 
European Journal of Orthopaedic Surgery and Traumatology, 26(1), 41–46. 
http://doi.org/10.1007/s00590-015-1698-y 
Olsen, Y., Daumit, G. L., & Ford, D. E. (2006). Opioid Prescriptions by U.S. Primary Care 
Physicians From 1992 to 2001. The Journal of Pain, 7(4), 225–235. 
http://doi.org/10.1016/j.jpain.2005.11.006 
Paige, N. M., Miake-Lye, I. M., Booth, M. S., Beroes, J. M., Mardian, A. S., Dougherty, P., 
… Shekelle, P. G. (2017). Association of Spinal Manipulative Therapy With Clinical 
Benefit and Harm for Acute Low Back Pain. Jama, 317(14), 1451. 
 48 
http://doi.org/10.1001/jama.2017.3086 
Park, H. J., & Moon, D. E. (2010). Pharmacologic Management of Chronic Pain. The 
Korean Journal of Pain, 23(2), 99. http://doi.org/10.3344/kjp.2010.23.2.99 
Parr, J., Borsa, P., Fillingham, R., Tillman, M., Manini, T., Gregory, C., & George, S. 
(2013). Pain Related Fear and Catastrophyzing predict pain intensity and disability 
independently using an induced muscle injury model. The Journal of Pain, 13(4), 
370–378. http://doi.org/10.1016/j.jpain.2011.12.011.Pain 
Patrick, N., Emanski, E., & Knaub, M. A. (2014). Acute and chronic low back pain. 
Medical Clinics of North America. Elsevier Inc. 
http://doi.org/10.1016/j.mcna.2014.03.005 
Paul-Savoie, E., Bourgault, P., Gosselin, E., Potvin, S., & Lafrenaye, S. (2015). Assessing 
patient-centred care for chronic pain: Validation of a new research paradigm. Pain 
Research & Management, 20(4), 183–8. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/26069896 
Pearce, N., Drysdon, E., Feyer, A., Gander, P., McCracken, S., & Wagstaffe, M. (2004). 
The Burden of Occupational Disease and Injury in New Zealand. Wellington. 
Phongamwong, C., & Deema, H. (2015). The impact of multi-site musculoskeletal pain on 
work ability among health care providers. Journal of Occupational Medicine and 
Toxicology, 10(1), 21. http://doi.org/10.1186/s12995-015-0063-8 
Pollard, C. A. (1984). Preliminary Validity Study of the Pain Disability Index. Perceptual 
and Motor Skills, 59(3), 974–974. http://doi.org/10.2466/pms.1984.59.3.974 
Rainville, P. (2002, April 1). Brain mechanisms of pain affect and pain modulation. 
Cognitive Neuroscience. Elsevier Current Trends. http://doi.org/10.1016/S0959-
4388(02)00313-6 
Rathleff, M. S., Roos, E. M., Olesen, J. L., & Rasmussen, S. (2013). High prevalence of 
 49 
daily and multi-site pain – a cross-sectional population-based study among 3000 
Danish adolescents. BMC Pediatrics, 13. Retrieved from 
http://www.biomedcentral.com/1471-2431/13/191 
Reichling, D. B., & Levine, J. D. (2010). Critical role of nociceptor plasticity in chronic 
pain. Trends in Neurosciences, 32(12), 611–618. 
http://doi.org/10.1016/j.tins.2009.07.007.Critical 
Reiner, K., Tibi, L., & Lipsitz, J. D. (2013). Do Mindfulness-Based Interventions Reduce 
Pain Intensity? A Critical Review of the Literature. Pain Medicine, 14(2), 230–242. 
http://doi.org/10.1111/pme.12006 
Roelofs, J., Van Breukelen, G., Sluiter, J., Frings-Dresen, M. H. W., Goossens, M., 
Thibault, P., … Vlaeyen, J. W. S. (2011). Norming of the Tampa Scale for 
Kinesiophobia across pain diagnoses and various countries. Pain, 152(5), 1090–1095. 
http://doi.org/10.1016/j.pain.2011.01.028 
Schofield, D. J., Shrestha, R. N., Passey, M. E., Earnest, A., & Fletcher, S. L. (2008). 
Chronic disease and labour force participation among older Australians. Medical 
Journal of Australia, 189(8), 447–450. http://doi.org/sch11012_fm [pii] 
Siddall, P. J., & Cousins, M. J. (1997). Spinal pain mechanisms. Spine, 22(1), 98–104. 
Stark, R. J., Ravishankar, K., Siow, H. C., Lee, K. S., Pepperle, R., & Wang, S. J. (2013). 
Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic 
review. Cephalalgia : An International Journal of Headache, 33(4), 266–83. 
http://doi.org/10.1177/0333102412468677 
Sturgeon, J. A., & Zautra, A. J. (2013). Psychological resilience, pain catastrophizing, and 
positive emotions: Perspectives on comprehensive modeling of individual pain 
adaptation topical collection on psychiatric management of pain. Current Pain and 
Headache Reports, 17(3). http://doi.org/10.1007/s11916-012-0317-4 
 50 
Swain, N., & Johnson, M. (2014). Chronic pain in New Zealand: a community sample - 
New Zealand Medical Journal, 127(1388). Retrieved from 
https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2014/vol-127-
no.-1388/articles-swain 
Swain, N., & Johnson, M. (2016). Chronic pain in New Zealand: a community sample - 
New Zealand Medical Journal, 127(1388). Retrieved from 
https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2014/vol-127-
no.-1388/articles-swain 
Tait, R. C., Chibnall, J. T., & Krause, S. (1990). The Pain Disability Index: psychometric 
properties. Pain, 40, 171–182. 
Tait, R. C., Pollard, C. a, Margolis, R. B., Duckro, P. N., & Krause, S. J. (1987). The Pain 
Disability Index: psychometric and validity data. Archives of Physical Medicine & 
Rehabilitation, 68(7), 438–441. 
Torrubia, R., Ávila, C., Moltó, J., & Caseras, X. (2001). The Sensitivity to Punishment and 
Sensitivity to Reward Questionnaire (SPSRQ) as a measure of Gray’s anxiety and 
impulsivity dimensions. Personality and Individual Differences, 31(6), 837–862. 
http://doi.org/10.1016/S0191-8869(00)00183-5 
Tsertsvadze, A., Clar, C., Ma, R. C., Clarke, A., Mistry, H., & Dphil, P. S. (2014). Cost-
Effectiveness of Manual Therapy for the Management of Musculoskeletal Conditions: 
A Systematic Review and Narrative Synthesis of Evidence From Randomized 
Controlled Trials. Journal of Manipulative and Physiological Therapeutics, 37(6), 
343–362. http://doi.org/10.1016/j.jmpt.2014.05.001 
Utter, A. A., & Basso, M. A. (2008). The basal ganglia: An overview of circuits and 
function. Neuroscience and Biobehavioral Reviews, 32(3), 333–342. 
http://doi.org/10.1016/j.neubiorev.2006.11.003 
 51 
Van Hecke, O., Hocking, L. J., Torrance, N., Campbell, A., Padmanabhan, S., Porteous, D. 
J., … Smith, B. H. (2017). Chronic pain, depression and cardiovascular disease linked 
through a shared genetic predisposition: Analysis of a family-based cohort and twin 
study. PLoS ONE, 12(2), 1–19. http://doi.org/10.1371/journal.pone.0170653 
Veehof, M. M., Trompetter, H. R., Bohlmeijer, E. T., & Schreurs, K. M. G. (2016). 
Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a 
meta-analytic review. Cognitive Behaviour Therapy, 45(1), 5–31. 
http://doi.org/10.1080/16506073.2015.1098724 
Vehof, J., Zavos, H. M. S., Lachance, G., Hammond, C. J., & Williams, F. M. K. (2014). 
Shared genetic factors underlie chronic pain syndromes. Pain, 155(8), 1562–1568. 
http://doi.org/10.1016/j.pain.2014.05.002 
Vlaeyen, J., & Linton, S. (2000). Fear-avoidance and its consequences in chronic 
musculoskeletal pain: a state of the art. Pain, 85(3), 317–32. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/10781906 
Vlaeyen, J. W. S., Crombez, G., & Goubert, L. (2007). The psychology of chronic pain and 
its management. Physical Therapy Reviews, 12(3), 179–188. 
http://doi.org/10.1179/108331907X223001 
Vlaeyen, J. W. S., Kole-Snijders, A. M. J., Boeren, R. G. B., & van Eek, H. (1995). Fear of 
movement/(re)injury in chronic low back pain and its relation to behavioral 
performance. Pain, 62(3), 363–372. http://doi.org/10.1016/0304-3959(94)00279-N 
von Baeyer, C. L., Lin, V., Seidman, L. C., Tsao, J. C., & Zeltzer, L. K. (2011). Pain charts 
(body maps or manikins) in assessment of the location of pediatric pain. Pain 
Management, 1(1), 61–68. http://doi.org/10.2217/pmt.10.2 
Voscopoulos, C., & Lema, M. (2010). When does acute pain become chronic? British 
Journal of Anaesthesia, 105 Suppl, i69–i85. http://doi.org/10.1093/bja/aeq323 
 52 
Vranceanu, A.-M., Bachoura, A., Weening, A., Vrahas, M., Smith, R. M., & Ring, D. 
(2014). Psychological Factors Predict Disability and Pain Intensity After Skeletal 
Trauma. The Journal of Bone & Joint Surgery, 96(3), e20–e20. 
http://doi.org/10.2106/JBJS.L.00479 
Waddell, G. (1987). A New Clinical Model for the Treatment of Low-Back Pain. Spine, 
12(7). 
Waddell, G. (1992). Biopsychosocial analysis of low back pain. Baillière’s Clinical 
Rheumatology, 6(3), 523–557. http://doi.org/10.1016/S0950-3579(05)80126-8 
Waddell, G., Newton, M., Henderson, I., Somerville, D., & Main, C. (1993). Fear-
Avoidance Beliefs Questionnaire (FABQ). Pain, 52, 157–168. 
Waddell, G., Newton, M., Henderson, I., Somerville, D., & Main, C. J. (1993). A Fear-
Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in 
chronic low back pain and disability. Pain, 52(2), 157–168. 
http://doi.org/10.1016/0304-3959(93)90127-B 
Wertli, M. M., Rasmussen-Barr, E., Held, U., Weiser, S., Bachmann, L. M., & Brunner, F. 
(2014). Fear-avoidance beliefs—a moderator of treatment efficacy in patients with low 
back pain: a systematic review. The Spine Journal, 14(11), 2658–2678. 
http://doi.org/10.1016/j.spinee.2014.02.033 
Wertli, M. M., Rasmussen-Barr, E., Weiser, S., Bachmann, L. M., & Brunner, F. (2014). 
The role of fear avoidance beliefs as a prognostic factor for outcome in patients with 
nonspecific low back pain: A systematic review. The Spine Journal, 14(5), 816–836. 
http://doi.org/10.1016/j.spinee.2013.09.036 
Wideman, T. H., Asmundson, G. J. G., Smeets, R. J. E., Zautra, A. J., Simmonds, M. J., 
Sullivan, M. J. L., … Edwards, R. R. (2013). Re-Thinking the Fear Avoidence Model: 
Toward a Multi-Dimensional Framework of Pain-Related Disability. Pain, 154(11), 
 53 
2262–2265. http://doi.org/10.1016/j.pain.2013.06.005 
Wideman, T., & Sullivan, M. (2011). Differential predictors of the long-term levels of pain 
intensity, work disability, healthcare use, and medication use in a sample of workers’ 
compensation claimants. Pain, 152(2), 376–383. 
http://doi.org/10.1016/j.pain.2010.10.044 
Williams, A., Eccleston, C., & Morley, S. (2012). Psychological therapies for the 
management of chronic pain (excluding headache) in adults. The Cochrane Database 
of Systematic Reviews, (11), 1–83. 
http://doi.org/10.1002/14651858.CD007407.pub3.www.cochranelibrary.com 
Woby, S. R., Roach, N. K., Urmston, M., & Watson, P. J. (2005). Psychometric properties 
of the TSK-11: A shortened version of the Tampa Scale for Kinesiophobia. Pain, 
117(1), 137–144. http://doi.org/10.1016/j.pain.2005.05.029 
Woodforde, J. M., & Merskey, H. (1972). Some relationships between subjective measures 
of pain. Journal of Psychosomatic Research, 16(3), 173–8. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/5072910 
Woolf, C. J., & Salter, M. W. (2000). Neuronal plasticity: increasing the gain in pain. 
Science, 288, 1765–1769. http://doi.org/10.1126/science.288.5472.1765 
Zale, E., & Ditre, J. (2015). Pain-Related Fear, Disability, and the Fear-Avoidance Model 
of Chronic Pain. Curr Opin Psychol, October, 24–30. 
http://doi.org/10.1016/j.copsyc.2015.03.014.Pain-Related 
Zorina-Lichtenwalter, K., Meloto, C. B., Khoury, S., & Diatchenko, L. (2016). Genetic 
predictors of human chronic pain conditions. Neuroscience, 338, 36–62. 
http://doi.org/10.1016/j.neuroscience.2016.04.041 
 
 1 
Section 2: Manuscript 
  
 2 
Behavioural activation and inhibition 
systems in relation to pain intensity and 
duration in a large chronic musculoskeletal 
pain sample 
 
 
 
 
Nina Sanson1, Sylvia Hach1, Robert Moran1 & Jesse Mason1 
 
 
 
 
1Health and Community Network, Unitec Institute of Technology, Auckland, New Zealand 
 
 
 
 
Running Head: Behavioural inhibition, activation and chronic pain 
 
 
 
 
Corresponding author: 
Nina Sanson 
Health and Community Network 
Unitec Institute of Technology, 
Auckland, 
New Zealand 
Ph: +64-274976773 
Email: osteo.nina@gmail.com   
 3 
Abstract 
Pain experience may be linked to an individual’s behavioural approach and avoidance 
(inhibition) tendencies. There is potential clinical utility in tailoring patients’ pain 
management treatments based on their behavioural tendencies. The current study aimed to 
extend work showing a link between behavioural approach/inhibition and pain experience 
by examining this relationship in a large population (n=709) affected by musculoskeletal 
pain. Pain intensity and pain duration were included in correlational analyses with 
behavioural activation and inhibition, fear-avoidance beliefs, kinesiophobia, and disability. 
Regression analyses to determine any predictive value of these variables on pain intensity 
or duration were also run. Finally, putative differences in activation and inhibition 
tendencies between groups reporting high and low pain intensities were tested. Findings 
showed significant positive relationships between pain intensity and fear-avoidance beliefs, 
kinesiophobia, and perceived disability, as well as positive relationships between pain 
duration and fear-avoidance, kinesiophobia and perceived disability. Fear-avoidance 
beliefs, kinesiophobia and disability accounted for 31% of the variance of the pain intensity 
data. Disability alone accounted for 5% of the variance within the pain duration data. 
Neither BIS nor BAS significantly related to or predicted pain intensity or duration and no 
differences in activation and inhibition tendencies were evident between high and low pain 
intensity groups. The present results show relationships between pain intensity and duration 
and fear-avoidance, kinesiophobia and disability consistent with the current literature. 
However, no relationships between BIS or BAS and pain intensity or duration were found. 
A closer examination of the BIS/BAS Scale as a measure of pain-related complaints is 
warranted.  
Key Words: BIS/BAS, behavioural inhibition, behavioural activation, pain, fear-
avoidance, kinesiophobia, disability.  
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Introduction 
Pain, particularly chronic pain, has a significant negative impact on social and financial 
resources regarding both the governmental and insurance spend as well as the personal cost 
and lost productivity (Damian Hoy et al., 2012; Pearce et al., 2004). Statistics from New 
Zealand’s Accident Compensation Corporation (ACC) indicate that both reported 
incidences of pain and the annual cost of pain is rising (ACC, 2016, 2017). Pain typically 
occurs in response to a noxious stimulus and, as a protective mechanism, can have an 
interruptive function on behaviour (Chris Eccleston & Crombez, 1999; Gatzounis, 
Schrooten, Crombez, & Vlaeyen, 2014). Further assessing the way in which pain and 
behaviour relate, measuring patient’s innate tendencies toward approach or avoidance 
(inhibitory) behaviours. This offers the potential for healthcare providers to offer a more 
tailored management for pain complaints and personalise recommendations based on this 
assessment (Jensen et al., 2016). 
 
Several models of pain encompass the interrelationship between the various aspects of pain 
experience. The biopsychosocial model of pain acknowledges Melzack and Wall’s gate 
control theory (1965) as the physiologic mechanism of pain. Illness behaviours and 
humans’ naturally social tendencies are included in the social aspect, and the psychological 
aspect is considered through how attitudes and beliefs toward pain can alter the way 
patients cope (Waddell, 1992; Waddell, 1987). The Fear-Avoidance Model considers how 
an individual’s history and beliefs may contribute to how threatening they perceive their 
pain to be, and therefore how likely they are to enter the negative feedback cycle the model 
proposes (Vlaeyen & Linton, 2000). The BIS/BAS model of chronic pain is based on the 
Reinforcement Sensitivity Theory, which suggests that there are two related 
neurophysiological systems that modulate behaviour based on rewarding or aversive 
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stimuli. The behavioural activation system (BAS), comprised of the basal ganglia and left 
prefrontal cortex, is stimulated during a positive stimulus, such as seeking food when 
hungry (Gray & McNaughton, 2000). Avoidance of movement (fear-avoidance) or fear of 
movement (kinesiophobia) in response to negative stimuli is generated by activation of the 
behavioural inhibition system (BIS) (Jensen et al., 2016). This system is formed largely in 
the amygdala, and contributes to the “stop, look, listen” response to fearful or threatening 
stimuli (Gray, 1990; Gray & McNaughton, 2000).  
 
The relationship between this two-part neurobiological system and pain perception has 
recently been explored in a couple of studies by Jensen, Tan, and Chua (2015), and Jensen 
et al. (2017). Using an asymptomatic student population, Jensen et al. (2015) found a 
positive correlation between the inhibition system, headache frequency and pain intensity, 
as well as a negative correlation between the activation system and headache frequency. 
The authors suggest that different approaches to pain management may result in greater 
effects for patients with dominance of either of the systems. This was expanded by Jensen 
et al. (2017) with a chronic pain population (n=83). They assessed pain intensity, 
behavioural inhibition, pain catastrophising, depressive symptoms, kinesiophobia, and pain 
interference. Their results showed that high behavioural inhibition predicted depression by 
12% after intensity has been controlled for. Kinesiophobia and catastrophising predicted 
depression 27% after both inhibition and intensity had been controlled for. They also found 
a significant interaction between behavioural inhibition and kinesiophobia when predicting 
depression. However, there were no significant findings relating behavioural inhibition with 
pain interference, kinesiophobia or catastrophising. Further exploration of the relationship 
between pain perception and behavioural tendencies could, therefore, provide findings 
leading to more effective pain management. The current study aims to extend this work 
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examining the putative relationship between inhibition and activation systems and pain to a 
large sample of individuals affected by persistent musculoskeletal pain. 
 
The intensity of a person's pain, although not necessarily indicative of tissue state, may 
indicate how much the pain is affecting that person, physically or emotionally (Chris 
Eccleston & Crombez, 1999), therefore it remains a key variable in this study. Furthermore, 
this study aims to expand on the research undertaken by Jensen et al. (2015) and Jensen et 
al. (2017) by examining a larger and more diverse sample population and by including the 
variables: duration, disability, fear avoidance beliefs and kinesiophobia. Jensen et al. (2015) 
found a significant relationship between headache frequency and BIS. Here, the sample has 
been expanded to include a symptomatic population of people experiencing 
musculoskeletal pain, excluding headache. Under the framework of the biopsychosocial 
model of pain, psychosocial variables such as fear-avoidance beliefs and kinesiophobia are 
often also assessed for when considering how a patient is being affected by their pain 
(Brox, 2014; Wertli, Rasmussen-Barr, Held, et al., 2014). In addition to these psychological 
variables, the impact pain has on individuals’ daily function and physical ability is vital to 
assess and, in line with recommendations by Dworkin et al. (2005) and Lee et al. (2015), 
we chose to include it here. Unlike Jensen et al. (2017), measures for depression and 
catastrophising were not included, as this study aimed to explore primarily movement-
related factors concerning pain experience and the behavioural systems, rather than 
focussing on emotional aspects. Further, rather than frequency of pain, duration has been 
selected as it is more common to report the pain duration in a clinical setting (Das, 2015; 
Rainville, 2002).  
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Associations between variables of pain intensity, pain duration, disability, kinesiophobia, 
and fear-avoidance beliefs have been demonstrated in previous studies (Denison, Åsenlöf, 
& Lindberg, 2004; Vranceanu et al., 2014; Wideman & Sullivan, 2011). However, to the 
authors’ knowledge, Jensen et al. (2017) is the only study to have examined the predictive 
power of behavioural tendencies on these established factors. Therefore, the aim of this 
study was to extend previous work by establishing whether average intensity and duration 
of musculoskeletal pain could be predicted by behavioural activation and inhibition 
tendencies and other known variables including fear-avoidance beliefs, kinesiophobia and 
disability in a sample of people reporting persistent musculoskeletal pain. 
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Methods 
Measures 
A web- and paper-based cross-sectional descriptive survey design using a convenience 
sample was implemented to identify the relationship between behavioural inhibition and 
activation (as measured by the Behavioural Inhibition and Activation Scale, BIS/BAS 
scale), pain-related fear and avoidance (Fear-Avoidance Beliefs Questionnaire), 
kinesiophobia (Tampa Scale for Kinesiophobia), disability (Pain Disability Index), pain site 
(as assessed with a Body Map) and pain level (Quadruple Visual Analog Scale, QVAS). A 
basic demographic section preceded the above instruments and pilot surveys were found to 
be acceptable. The study was approved by the local ethics committee and informed consent 
was implied by submission of the completed survey (UREC 2016-1069).   
 
Data Collection 
A composite questionnaire of the collated measures was prepared for administration using 
an online application (SurveyMonkey, Palo Alto, CA, USA) and advertised widely via 
Facebook Advertising to appeal to a range of demographics. In addition, printed 
questionnaires were distributed to all patients attending our clinical centre over a three-
month data collection period. Assessment of pain symptomology relied on participants’ 
self-report. Completion of the questionnaire took approximately 10 minutes, and no 
inducements were offered. 
 
BIS/BAS Scale 
Carver and White's BIS/BAS Scale (1994) is one of the most widely used measures to 
assess dominance of an individual’s inhibition and activation systems (Demianczyk, 
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Jenkins, Henson, & Conner, 2014). The 24-item Likert-type scale provides a numerical 
rating on activation of both systems with higher scores indicating more activation and 
lower scores indicating less activation (Carver & White, 1994a). However, the two 
subscales are not inversely related (Jensen, Ehde, & Day, 2016). The BIS/BAS Scale has 
been found to be a valid and reliable tool, with all four subscales having internal 
consistencies ranging from .66 to .76, and test-retest reliabilities of  .59 to .69 (Carver & 
White, 1994a; Cogswell et al., 2006). Currently, there does not appear to be a consensus in 
other literature regarding threshold values for a high or low score (Carver & White, 1994; 
Demianczyk et al., 2014; Gray, Hanna, Gillen, & Rushe, 2016; Jorm et al., 1998).  
 
Tampa Scale for Kinesiophobia 
The Tampa Scale for Kinesiophobia (TSK-11) is a widely used instrument for assessing 
kinesiophobia in back pain patients (Woby, Roach, Urmston, & Watson, 2005). It is an 11-
item scale developed by removing items that demonstrated poor validity in the original 
TSK (Miller, Kori, & Todd, 1995). The TSK-11 shows improved psychometric properties 
compared to the original TSK (internal consistency: TSK a=0.76 versus TSK-11 a=0.79; 
reliability: TSK ICC=0.82 versus TSK-11 ICC=-0.81) with the advantage of being shorter 
to implement. Scoring for the TSK-11 ranges from 11 to 44, the higher score representing 
more kinesiophobia/fear of re-injury (Woby et al., 2005).  
 
Fear Avoidance Beliefs Questionnaire 
The Fear-Avoidance Beliefs Questionnaire (FABQ) is a 16-item measure capturing fear-
avoidance beliefs in patients affected by low back pain (Waddell, Newton, Henderson, 
Somerville, & Main, 1993). There are two subscales within the FABQ: Physical Activity 
(FABQ-PA) and Work (FABQ-W), which assess the potential for fear in physical activity 
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and the individual's work respectively. The initial study of this questionnaire by Waddell et 
al. (1993) found the measure to be reliable (k=0.61, p=0.001). Further psychometric 
evaluation by George, Valencia, and Beneciuk (2010) found concurrent validity between 
the FABQ-PA subscale and kinesiophobia (TSK-11, r=0.62), but weak concurrent validity 
between the FABQ-W subscale and TSK-11 (r=0.38). In order to minimise overlap with 
items from the kinesiophobia scale, the current study includes the FABQ-W subscale only.  
 
Visual Analogue Scale 
The Visual Analogue Scale (VAS) is a widely used tool to measure the intensity of patient's 
pain (Hawker, Mian, Kendzerska, & French, 2011; Woodforde & Merskey, 1972). The 
VAS has good test-retest reliability (r=0.94) and has demonstrated sensitivity to changes in 
pain over as little as four hours (p<0.001). There are several versions of this scale, one 
widely used version of which is the Quadruple Visual Analogue Scale (Q-VAS). This 
instrument presents the patient with four identical scales, asking them to report intensity of 
the 1) pain right now, 2) average pain, 3) pain level at its best, and 4) pain level at its worst. 
The answers are then averaged, giving a more precise indication of the average pain levels. 
Due to an absence of differences between the total pain score and Q-VAS score for Pain 
Right Now (Q-VAS RN), the predominant use of current pain ratings in clinical practice 
and in Jensen et al.’s (2017, 2015) work, only values for “pain right now” (Q-VAS RN) 
were included in the final analysis of this study. 
 
Body Map 
The Body map is a drawing of a body, front, back and sides, on which patients can indicate 
the area(s) in which they perceive pain (Margolis, Tait, & Krause, 1986). Body maps are 
widely used both clinically and in research for assessing painful areas, as they are simple to 
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understand and quick to administer (Herr & Garand, 2001; von Baeyer, Lin, Seidman, 
Tsao, & Zeltzer, 2011). Body mapping has demonstrated high inter-rater reliability (0.96-1) 
(Margolis et al., 1986). 
 
Pain Disability Index 
The Pain Disability Index (PDI) was designed by Pollard (1984) as a subjective measure of 
disability to complement findings of physical examination. The PDI has seven scales  
pertaining to various aspects of life, such as home responsibilities, social, and life-support 
activities. The total scoring indicates the level of disability ranging from “no disability” to 
“worst disability”. Psychometric evaluation found the PDI to be internally consistent 
(α=.86), valid, and with a moderate test-retest reliability (Tait, Pollard, Margolis, Duckro, 
& Krause, 1987; Tait, Chibnall, & Krause, 1990). It also correlates well with the well-
known Oswestry Disability Questionnaire (Grönblad et al., 1993).  
 
Data reduction 
On completion of data collection, raw data were downloaded and responses from printed 
questionnaires entered before data checking and cleaning. Inclusion criteria stipulated that 
only responses from adults currently living in New Zealand between the ages of 16 and 69 
years without any known cancer history were included. 
 
Total scores for each of the measures (BIS, BAS, FABQ-W, TSK-11, PDI) were calculated 
(Table 2). Duration scores were converted into weeks, ranging from 3 to 260 weeks. 
Participants were grouped by the number of pain sites rather than by pain location. This 
decision was supported by research suggesting that pain site has little influence on 
prognosis (de Vos Andersen et al., 2017). Participants were categorised as belonging to one 
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of two groups: few pain sites (1 or 2 sites) or many pain sites (≥3 sites) (Phongamwong & 
Deema, 2015).  
 
Statistical Analysis  
All analyses were carried out using SPSS v.24. All measures were screened for normality 
using SPSS and standard guidelines for sphericity and kurtosis. In the case of violations of 
the assumption of normality equivalent, non-parametric tests were employed. There was 
linearity as assessed by partial regression plots and a plot of studentized residuals against 
the predicted values. There was independence of residuals, as assessed by a Durbin-Watson 
statistic of 2.078 for intensity and 1.947 for duration. There was some evidence of 
multicollinearity between independent variables TSK and PDI, and FABQ and PDI as 
assessed through a correlations table (see table 4), but correlation values did not exceed a 
critical threshold of .80 and Variance Inflation factor values similarly did not exceed the 
critical threshold of 10 (Field, 2009). Therefore, no variables were omitted in the 
subsequent analyses. Intensity had two studentized deleted residuals: one with a value of 
3.003, and one with a value of -3.067. These cases were not removed. Duration did not 
have any studentized deleted residuals greater than ±3 standard deviations. Neither pain 
intensity nor pain duration had leverage values greater than 0.2, or values for Cook's 
distance above 1.  
 
A total of 1402 adults participated in the survey; 94 participants (6.7%) completed the 
survey on paper at the Unitec Osteopathy Clinic, and 1308 participants (93.3%) completed 
the survey online. Incomplete datasets or datasets completed by participants not fulfilling 
the inclusion criteria for age were excluded. The final data set consisting of 709 responses 
were used for all analyses (see Table 1 for demographic information). Excluded cases did 
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not differ significantly in terms of gender or ethnicity (gender χ(1)=0.001, p=.973; ethnicity 
χ(1)=4.482, p=.482.). There was a significant age difference between included and 
excluded cases (included Mdn age=46, excluded Mdn age=53, U=19717.5, z=-3.353, 
p=.001) due to the inclusion parameters (see data collection). In addition, participants that 
met the inclusion criteria reported a significantly greater number of pain sites (Mdn=2) 
compared to participants that were not included (Mdn=1) (U=135393.5, z=-15.083, 
p<.001).  
 
Analyses were carried out in two steps. The primary analysis was conducted in order to 
emulate Jensen et al.(2015). For this, pain intensity (QVAS-RN) scores were trichotomized 
(Gelman & Park, 2009) to assess the potential of group difference between participants 
reporting low-intensity pain at the time of testing and those reporting high pain intensity. 
Secondary analyses of continuous measures included Spearman’s rho to explore 
correlations between dependent variables (pain intensity and pain duration) and 
independent variables (fear-avoidance beliefs, kinesiophobia, disability, BIS and BAS). In 
addition, two multiple regressions were run in order to estimate the extent to which FABQ, 
TSK, PDI, BIS, and BAS predict pain intensity and pain duration respectively.  
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Results 
Table 1 displays participant demographics.  The sample was 80% female and 
predominantly of New Zealand European ethnicity (17% from other ethnic backgrounds). 
The mean number of pain sites was 3.10, average pain duration 2.6 years, and average pain 
intensity 4.09 (from a maximum of 10) (see Table 2 for a summary).  
 
Table 1: Demographic Information of Participants 
Variables Mean (SD) Number (%) 
Gender 
   Male 
   Female 
 
 
 
142 (20) 
566 (80) 
Age (y) 44.28 (13.77)  
Ethnicity 
   NZ/European 
   Maori 
   Pacific Island 
   Asian 
   Other 
 
 
 
 
 
 
 
585 (83) 
30 (4) 
12 (2) 
7 (1) 
69 (10) 
 
Descriptive statistics for each scale (shown in Table 2) are similar to those reported in 
comparable studies (Carver & White, 1994; Jorm et al., 1998; George et al., 2010; Waddell, 
Newton, Henderson, Somerville & Main, 1993; Tait et al., 1990; Phongamwong & Deema, 
2015; Hawker et al., 2011). The number of pain sites is typically classified as 1-2 = few, 3-
4 = many (Phongamwong & Deema, 2015). By this classification, the mean number of pain 
sites for the present participant group is “many”. The mean pain intensity of 4.09 is mild, as 
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0.5 - 4.4 is classified as mild pain intensity (Hawker et al., 2011). The mean duration is 
2.68 years indicating chronic pain. According to Waddell, Newton, Henderson, Somerville, 
and Main (1993), <19 suggests low Fear-Avoidance Beliefs in relation to Work. With a 
mean of 15.46, these participants are in the low fear-avoidance group, but have more fear-
avoidance beliefs than other chronic pain patients, as George et al. (2010) had a mean of 
13.9 in participants experiencing chronic low back pain. 
 
Table 2: Sample averages, standard deviations, range and descriptors for the 
measures included 
 Measures Mean SD Range  
BIS 19.9 4.0 7 – 28 
BAS 36.3 6.1 14 – 51 
BAS FS 10.7 2.3 4 - 16 
BAS D 10.0 2.3 4 - 16 
BAS RR 15.5 3.1 5 – 20 
TSK-11 25.2 5.6 11 – 43 
FABQ-W 15.5 10.6 0 – 42 
PDI 20.0 14.1 0 – 60 
Number of Pain Sites 3.1 3.1 1 – 20 
QVAS RN 4.1 2.4 0 – 10 
Duration 140.0  92.4 3 – 260 weeks 
BIS= Behavioural Inhibition System, BAS= Behavioural Activation System, BAS Subscales FS= Fun 
Seeking, D= Drive, RR= Reward Responsiveness, TSK-11= Tampa Scale for Kinesiophobia, FABQ-W= 
Fear-Avoidance Beliefs (Work), PDI= Pain Disability Index.  
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In the first step of the analysis, the dataset was trichotomized (Gelman & Park, 2009) based 
on pain intensity scores (QVAS RN). Mann-Whitney U tests of BIS and BAS were 
performed between participants reporting low pain intensity (Mdn=2) and participants 
reporting high pain intensity (Mdn=8). There was no significance in BIS or BAS compared 
to high or low pain intensity groups. There was also no significant difference between the 
high and low pain intensity groups and the BAS subscales of Fun Seeking, Drive Reward 
Responsiveness. 
 
Table 3: Spearman’s Rho Correlations between Dependent and Independent 
Variables 
 
Independent Variables 
Rho Value 
Pain intensity (QVAS RN) Pain duration (weeks) 
Behavioural Inhibition (BIS) -.064 .054 
Behavioural Activation (BAS) -.018 .052 
Kinesiophobia (TSK-11) .322*** .153** 
Fear-Avoidance Beliefs (FABQ-W) .338*** .106** 
Disability (PDI) .515*** .189*** 
*** p<.001; ** p<.01; * p<.05 
 
The second step of analysis included production of Spearman’s rho to explore correlations 
between dependent and independent variables. Table 3 shows the magnitude and direction 
of relationships between the dependent (pain intensity; pain duration) and independent 
variables (BIS, BAS, TSK-11, FABQ-W, PDI). There was no significant correlation 
between pain intensity (QVAS RN) and measures of BIS or BAS (both p>.05). However, 
employing Hopkins (1997) magnitude of effect descriptors, there were significant and 
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moderate positive correlations pain intensity and kinesiophobia (TSK; rho=.322, <.001), 
fear-avoidance beliefs (FABQ; rho=.338, p<.001), and significant, large positive 
correlations between pain intensity and disability (PDI; rho=.515, p<.001). There was also 
a significant but small positive correlation between measures of pain intensity and pain 
duration (rho=.108, p<.01). For pain duration, no significant correlation was found between 
pain duration and measures of BIS or BAS (both p>.05). There was a significant positive 
relationship with kinesiophobia (rho=.153, p<.001), fear-avoidance (rho=.106, p<.01), and 
disability (rho=.189, p<.001).  
 
There was a moderate correlation between BIS and BAS scores (rho=.313, p<.001). In this 
sample, BIS also correlated weakly with kinesiophobia (rho=.120, p<.01). There are no 
other significant correlations between BIS or BAS and other variables. Kinesiophobia, fear-
avoidance beliefs, disability, pain duration and pain intensity all correlated significantly and 
positively with each other (see Table 4 for all intercorrelations).  
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Table 4: Spearman’s Rho Correlations Between Independent Variables  
  Correlation coefficient (rho) p-value 
BIS BAS .313*** <.001 
TSK-11 .120* <.01 
FABQ-W -.007 n/sig 
PDI -.016 n/sig 
BAS TSK-11 .050 n/sig 
FABQ-W .052 n/sig 
PDI -.071 n/sig 
TSK-11 FABQ-W .347*** <.001 
PDI .506*** <.001 
FABQ-W PDI .422*** <.001 
*** p<.001; ** p<.01; * p<.05 
 
Finally, multiple linear regression models were estimated in order to determine which of 
the factors included in the present study were predictive of pain intensity (QVAS RN) and 
pain duration. The first multiple regression model (Table 5) showed that pain intensity 
(QVAS RN) was significantly predicted by TSK-11, FABQ-W and PDI, F(5, 701)=61.541, 
p<.001, adj. R2=.305. That is, TSK-11, FABQ-W and PDI were able to predict 31% of the 
variance in pain intensity in this dataset. In contrast, BIS and BAS were not able to 
significantly predict pain intensity. 
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Table 5. Linear regression of Model 1 (measures of Behavioural Inhibition, 
Behavioural Activation, Kinesiophobia, Fear Avoidance Beliefs and Perceived 
Disability on pain intensity in the study sample).  
DV: Pain Intensity 
 
R2 = .305  Model Sig. 
= <.001 
 
 Unstandardised 
β 
95% CI 
Lower Limit 
95% CI 
Upper Limit 
SEB Standardised 
β 
BIS -.031 -.07 .01 .021 -.051 
BAS -.004 -.03 .02 .014 -.11 
TSK-11 .038 .01 .07 .016 .086* 
FABQ-W .032 .02 .05 .008 .142*** 
PDI .071 .06 .08 .007 .418*** 
DV= Dependent Variable; BIS= Behavioural Inhibition System, BAS= Behavioural Activation System, TSK-
11= Tampa Scale for Kinesiophobia, FABQ-W= Fear-Avoidance Beliefs (Work), PDI= Pain Disability Index.  
*** p<.001; ** p<.01; * p<.05; β=unstandardised regression coefficient; SEB=standard error of the 
coefficient; CI = Confidence Interval 
 
The second multiple regression model (Table 6) showed that pain duration could be 
significantly predicted by PDI, F(5, 702)=6.996, p<.001, adj. R2=.047. Only the predictor 
PDI contributed to this model and accounted for 5% variance within pain disability. None 
of the other variables (BIS, BAS, TSK-11 or FABQ-W) added significantly to the fit of the 
model. Regression coefficients and standard errors can be found in Tables 5 and 6 (above). 
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Table 6. Linear regression of Model 2 (measures of Behavioural Inhibition, 
Behavioural Activation, Kinesiophobia, Fear Avoidance Beliefs and Perceived 
Disability on pain duration in the study sample).  
DV: Pain Duration 
 
R2 = .047 Model Sig. = <.001  
 Unstandardiz
ed β 
95% CI 
Lower Limit 
95% CI 
Upper Limit 
SEB Standardised 
β 
BIS .807 -1.08 2.69 .962 .034 
BAS .872 -.33 2.08 .615 .058 
TSK-11 1.272 -.17 2.72 .736 .076 
FABQ-W .225 -.50 .95 .370 .026 
PDI .905 -.32 1.49 .298 .138** 
DV= Dependent Variable; BIS= Behavioural Inhibition System, BAS= Behavioural Activation System, TSK-
11= Tampa Scale for Kinesiophobia, FABQ-W= Fear-Avoidance Beliefs (Work), PDI= Pain Disability Index.  
*** p<.001; ** p<.01; * p<.05; β=unstandardised regression coefficient; SEB=standard error of the 
coefficient; CI = Confidence Interval 
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Discussion 
The main aim of this study was to investigate the extent to which intensity and duration of 
musculoskeletal pain could be predicted by behavioural activation and inhibition tendencies 
and other known variables including fear-avoidance beliefs, kinesiophobia and disability. 
This was carried out to test and extend recent studies by Jensen et al. (2015, 2017), which 
provided the first indication of significant relationships.  
 
Comparing the current average scores to those reported in similar studies shows low 
disability (20.06) in the present sample compared to other studies (32.5-34.5) (Tait et al., 
1990) and marginally low Reward Responsiveness (15.54, as assessed by the BAS-RR 
subscale of the Behavioural Activation Scale) compared to other studies (15.0 – 
17.6)(Carver & White, 1994a; Jorm et al., 1998). All other average scores reported here 
match those reported in other literature. BIS average was 19.90 here compared to 19.99 
(Carver & White, 1994a), and 19.3 – 22.0 depending on age range and gender (A. Jorm et 
al., 1998). The total BAS score is 36.30, which fits within an average range from 33.6 - 
40.2 (A. Jorm et al., 1998). For BAS FS the average was 10.75, otherwise a range of means 
has been reported from 9.5 – 12.3, and for BAS D the average was 10.02 while others 
report a range of 8.2 – 10.9 (A. Jorm et al., 1998). Kinesiophobia also scored similarly to 
other reports, with the current study averaging 25.16 compared to 24.5 – 44.2 in 3085 
participants with a range of pain complaints (Roelofs et al., 2011), and 22.6 in 53 chronic 
low back pain patients (George et al., 2010). 
 
BIS and BAS  
 In contrast to the results of Jensen et al. (2015), this study did not identify a significant 
relationship between pain intensity or pain duration and BIS or BAS, and neither BIS nor 
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BAS were predictors for pain intensity or duration. These findings are in contrast to the 
results of Jensen et al. (2015) but in partial agreement with the results of Jensen et al. 
(2017).  
 
It has been theorised that once pain reaches a moderate intensity (a score of more than four 
out of a possible ten on a visual rating scale (Chris Eccleston & Crombez, 1999)), it can 
have an interruptive, protective function, which Jensen et al. (2015) suggested could relate 
to behavioural tendencies. The average pain intensity within this participant group was low, 
so may not have interrupted behaviour, potentially explaining why we did not find any 
significant relationships between BIS, BAS and pain intensity. However, Jensen et al. 
(2017) reported a moderate pain intensity, yet their results did not support a relationship 
between behavioural inhibition and pain intensity. In light of these contrasting findings, the 
nature of the relationship between behavioural inhibition and pain intensity would benefit 
from further exploration.  
 
The present data showed a significant positive relationship between BIS and kinesiophobia. 
This is supported by Jensen et al.’s (2016) BIS/BAS Model of pain, which suggests that 
people who are high in BIS at baseline may be more prone to developing kinesiophobia in 
the presence of pain (Jensen et al., 2016) and may also be more likely to be affected by 
depression (Jensen et al. (2017) . A relationship between behavioural inhibition and 
kinesiophobia may suggest that avoiding potentially painful movements could relate to the 
development and persistence of chronic pain conditions, as described the Fear-Avoidance 
model (Vlaeyen & Linton, 2000; Wertli, Rasmussen-Barr, Held, et al., 2014). Indeed, work 
by Vlaeyen et al. (1995) found  that kinesiophobia did relate to pain intensity coping, 
higher scores for kinesiophobia displayed more avoidance in movement tasks. 
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Results of the current study also showed a significant positive relationship between BIS and 
BAS. This supports some of the suggestions made by Jensen et al. (2016) that BIS and 
BAS are not mutually exclusive, but rather function together. Behavioural inhibition and 
activation are postulated to be separate systems in different brain areas that respond to 
different environmental cues, but that overlap in some areas (for example the presence of a 
threat may cause a momentary increase in inhibitory behaviours and a simultaneous 
decrease in activation behaviours).  
 
Reward responsiveness can be altered in patients with chronic pain (Becker, Gandhi, & 
Schweinhardt, 2012). A study by Elvemo, Landrø, Borchgrevink, and Haberg (2015) found 
reward responsiveness to be significantly reduced in chronic pain patients (p=.005) 
compared to matched healthy controls. As the pain duration for the present participant 
group is in the chronic range (average 2.7 years) the findings by Elvemo et al. (2015) could 
explain why this population scored lower than average in reward responsiveness, as 
compared to studies by Carver and White (1994a) and Jorm et al. (1998) which were not 
assessing participants based on pain, but rather personality traits.  
 
Intensity Regression (Independent Variables that Predict Pain Intensity) 
The extent to which scores for BIS, BAS, kinesiophobia, fear-avoidance beliefs and 
disability could predict pain intensity was examined. Pain intensity was predicted by 
variables kinesiophobia, fear-avoidance beliefs and disability, accounting for 31% of the 
variance in this dataset. There are a number of studies examining the predictive ability of 
these variables for pain intensity. Parr et al. (2013) showed fear of pain to be the strongest 
predictor of pain intensity from baseline to follow up (96 hours) after inducing 
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experimental pain. They also found catastrophic thinking to be a strong predictor of pain 
intensity, and kinesiophobia to be a strong predictor of disability. These findings are also 
reported in other populations, discussed above.  
 
Duration Regression (Disability as a Predictor of Pain Duration) 
In addition to examining potential predictors of pain intensity, predictors of pain duration 
were also examined. Disability was the only variable to predict pain duration and accounted 
for 5% of the variance within the pain duration dataset. There was no statistically 
significant predictive value found of kinesiophobia or fear-avoidance beliefs on pain 
duration within this dataset. A review by Wertli, Rasmussen-Barr, Weiser, et al. (2014) 
states that the reported pain durations differed widely between the articles they assessed, 
making it difficult to draw any conclusions about how other variables, such as fear-
avoidance beliefs, may relate to specific durations of pain. Instead, when pain duration is 
directly examined, it is more often in a controlled environment of experimentally induced 
pain which is typical of short-term duration and therefore not easily generalised to a wider 
population (Parr et al., 2013). It has been theorised as part of the Fear-Avoidance Model of 
pain that disability could increase as pain duration increases through physical 
deconditioning secondary to avoiding movements or activities that may cause, or 
historically have caused, pain (Wideman et al., 2013). The lack of a predictive association 
between pain duration and fear avoidance beliefs in this study is interesting as it would 
suggest that there is no clear predictive value of fear-avoidance beliefs on the duration of 
patient's pain in a large sample of chronic low-intensity musculoskeletal pain sufferers. 
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Correlations 
Results of this study showed a strong positive relationship between pain intensity and 
disability, and a moderate positive relationship between pain intensity and fear-avoidance 
beliefs and kinesiophobia. These relationships have previously been reported, often in 
conjunction with other psychological factors. For example, a study by Arnstein, Caudill, 
Mandle, Norris, and Beasley (1999) found that high pain intensity related with higher 
disability, and with lower self-efficacy. A second example by Denison, Åsenlöf, and 
Lindberg (2004) found that pain intensity explained a significant proportion of the variance 
in disability scores in a large sample of musculoskeletal pain patients. Thirdly, Vranceanu 
et al. (2014) found that psychological variables including catastrophic thinking, pain 
anxiety and depression were strongly associated with pain intensity and disability. 
Altogether, this suggests that the present dataset represents what is currently known about 
interrelationships between psychological variables.  
 
There were weak positive relationships between pain duration and fear-avoidance beliefs, 
kinesiophobia and disability. Pain duration has not been noted to relate to disability, fear-
avoidance beliefs or kinesiophobia in similar studies of chronic pain patients (Crombez, 
Vlaeyen, Heuts, & Lysens, 1999; Denison et al., 2004), and subacute stage patients 
(Wideman & Sullivan, 2011). A review by Wertli, Rasmussen-Barr, Weiser, Bachmann, 
and Brunner (2014) found that in patients who had had pain for four weeks to six months, 
high fear-avoidance beliefs were prognostic of delayed return to work/higher number of 
pain-related sick days. They also noted that in very acute (<3 weeks) and chronic (>3 
months) pain populations, there was no relationship between fear-avoidance beliefs and 
pain duration or disability. This suggests that fear-avoidance beliefs may have more impact 
 26 
on pain duration within 3 – 12 weeks post-injury. So, although there is some evidence to 
suggest there is a relationship between fear-avoidance beliefs and pain duration, as the 
current data set has shown, these variables are not widely found to significantly relate to 
pain duration.  
 
Consistent with Denison et al. (2004), there were significant positive relationships between 
kinesiophobia, fear-avoidance beliefs and disability. Similarly, Vlaeyen et al. (1995) 
showed that kinesiophobia was closely related to catastrophising, depression, and also to 
pain intensity. Both Denison et al. (2004) and Vlaeyen et al. (1995) examined participants 
experiencing musculoskeletal pain in a primary healthcare setting, similarly to the current 
participant group. In summary, while there is mild variability between the present study and 
previous findings detailing interrelationships between pain intensity, pain duration, 
kinesiophobia, fear-avoidance beliefs and disability, the current results are broadly in line 
with the existing literature.  
 
Comparison of current study with previous literature 
The general framework of the current study and Jensen et al. (2015) was similar, in both 
used a survey to collect data on BIS and BAS levels using the BIS/BAS Scale (Carver & 
White, 1994b) while also asking about pain in various body locations and the intensity of 
that pain. However, there were several methodological differences between our study and 
those of Jensen et al. (2015, 2017), these include sample characteristics (size, age and 
ethnicity), the measures used (including how the BIS/BAS Scale was utilised, pain intensity 
measures, and the use of pain duration rather than frequency), and statistical analysis. 
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 The current study involved a larger sample population (n=709 compared to n=563, and 
n=88 respectively). Regarding sample population, the chances of discovering trends in the 
data may be increased by having a more homogeneous sample population, as in Jensen’s 
studies. However, having a larger, more heterogeneous sample population may mean 
results are more representative of the general population, and therefore more generalizable 
and clinically applicable.  
 
The current sample population had much more variance in age (Mean (SD) = 44.28 
(13.77)) compared to Jensen et al. (2015) (Mean (SD) = 19.78 (1.29)), and slightly more 
than Jensen et al. (2017) (Mean (SD) = 52.90 (11.35)). There does not appear to be any 
difference in pain or pain reporting within younger or older adult populations (Herr & 
Garand, 2001; von Baeyer et al., 2011) so it is unlikely that different mean ages have 
affected the differences in results. 
 
Regarding participant's cultural and ethnic backgrounds, most of Jensen et al. (2015) 
participants were Chinese, and Jensen et al. (2017) were Canadian, whereas the current 
population sample was made up predominantly of New Zealand Europeans. Pain 
experience (pain intensity, impact on life and disability) between New Zealand Europeans 
and Chinese immigrants living in New Zealand is suggested to be similar (Ho & Johnson, 
2013). However, the response to pain between these two groups was different, with more 
New Zealand Europeans seeking medical help and social support than Chinese immigrants. 
The authors reported difficulty in comparing these results to studies of Chinese people in 
China, as many of those studies are condition-specific. They also noted that many of their 
Chinese participants also demonstrated signs of western acculturation regarding health 
management approaches, therefore a comparison of New Zealanders and Chinese in China 
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could yield different results. Ethnicity has been shown to relate to differences in pain 
reporting among other groups. For example, Day and Thorn (2010) found ethnic 
background to be a unique predictor of pain reporting between two ethnic groups in the 
USA, with African-Americans reporting significantly higher pain intensities than White 
Americans. Additionally, Hobara (2005) found a significant effect of both sex and culture 
on the acceptability of pain behaviours across Japanese and Euro-American adults. These 
findings suggest that, although different ethnic and cultural backgrounds may account for 
some difference in pain reporting, no specific conclusions can be drawn on how ethnicity 
may have affected the results of this study compared with Jensen et al. (2015) and Jensen et 
al. (2017). 
 
Secondly, the current study and both Jensen et al. (2015) and Jensen et al. (2017) all 
utilised Carver and White’s (1994) BIS/BAS Scale to assess levels of BIS and BAS. 
However, Jensen et al. (2015) only used five BIS items rather than all seven – they 
removed the reverse-scored items to increase the internal validity of the BIS scale. Jensen 
et al. (2017) only used the BIS subscale, and not the BAS subscales. Either of these 
alterations to the BIS/BAS Scale could account for some variation in BIS scores and 
results. Additionally, pain intensity scores were captured with the use of different measures. 
For pain intensity, the current study employed a quadruple Visual Analogue Scale (Q-VAS) 
score to assess participants' average pain intensity per pain site, whereas Jensen et al. 
(2015) and Jensen et al. (2017) used a Numerical Rating Scale for their pain intensity at 
bothersome areas over the past week. Clinically, the Numerical Rating Scale for pain 
intensity over the past week would be quick to use and provide a sufficient baseline. 
However, in research, particularly when considering cases of chronic pain, it may be more 
valid to use a measure such as the Q-VAS, which provides an average score that is 
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representative of all the pain intensities the participant feels in relation to their chronic pain. 
The difference in pain intensity measures may also have contributed to discrepancies in 
results between the two studies and thereby influencing the relationship between pain 
intensity and the BIS/BAS measures. 
 
Further exploring the differences in measures between the current study and Jensen et al. 
(2015), while they drew a focus to headache frequency, this study did not analyse a specific 
pain area but instead assessed the number of pain sites for participants. Headaches are often 
one of the more common complaints in young adults, which may explain why Jensen and 
colleagues chose to analyse them (Dunn, Jordan, Mancl, Drangsholt, & Le Resche, 2011). 
However, there is such variability in causes for headaches, such as stress and medication 
overuse, that do not necessarily represent musculoskeletal pain (Aaseth et al., 2008; Stark et 
al., 2013). Therefore headaches were not specifically assessed for this study.  
 
Another key difference in the assessment of pain between the current study and Jensen et 
al. (2015) was frequency versus duration. Frequency of pain has been used in child and 
adolescent populations, presumably where persistent or chronic pain is less prevalent (Dunn 
et al., 2011; Rathleff, Roos, Olesen, & Rasmussen, 2013). However, frequency of pain does 
not seem to be the most clinically useful way of considering pain when compared to the 
acute or chronic definitions that are most commonly used in other literature (Das, 2015; 
Hoy, Brooks, Blyth, & Buchbinder, 2010). Therefore the present study assessed pain 
duration instead of pain frequency. We also included additional measures for fear-
avoidance beliefs, kinesiophobia and disability, as well as asking about participants’ 
duration of pain. These established variables were included to further the BIS/BAS Model 
of chronic pain by assessing how they relate to the behavioural systems.  
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Finally, the methods of statistical analysis are different between this study and the two by 
Jensen and colleagues (Jensen et al., 2015; Jensen et al., 2017). The current study utilised 
non-parametric correlations and regression analyses, whereas Jensen et al. (2015) have used 
a series of ANOVAs. Although it is highly likely that Jensen's dataset was normally 
distributed since it was reasonably homogeneous with regard to demographics, the authors 
did not report data screening procedures, and it is therefore not possible to assess whether 
the use of parametric testing was justified. On the one hand, by using nonparametric testing 
we may not have picked up on trends emerging that may have come to light within Jensen's 
results. However as we did have a skewed dataset, this should not have been the case, as 
non-parametric tests are only less powerful when there are no violations of normality 
(Field, 2009). On the other hand, using repeated 1-way ANOVAs does increase the risk of 
over-reporting emerging trends, whereas regression approaches are more robust to this 
because all variables are added to the analysis at once. The study by Jensen et al. (2017) 
was more similar in analysis: they reported a normally distributed dataset and employed a 
hierarchical linear regression. Though there were differences in analyses between the three 
studies, assuming each dataset was tested based on its assumptions of normality, the results 
should be reasonably robust in all. 
 
The theory of behavioural inhibition and activation playing a role in how pain is perceived 
is still plausible despite the lack of findings in this study. While the theory of a two-factor 
neurophysiological system has been tested in other areas, such as personality and 
motivations, more examination around their relation to pain is indicated here. Considering 
pain, particularly chronic pain, from a perspective of behavioural activation and inhibition 
offers a unique, yet plausible take on patient presentation and provides more focused 
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treatment options (Jensen et al., 2016). However, a limitation of this theory, and indeed of 
this study, seems to be the measure of BIS and BAS. 
 
Limitations 
This study relied on self-report or pain symptomology rather than any clinical analysis. 
This, coupled with the recruitment strategy of advertising on Facebook, could have allowed 
for participants over- or under-reporting of symptoms. There was also no control in place to 
screen for confounding factors such as mental health status or the use of medications that 
may alter pain experience, neurobiology and emotion regulation. These could all have 
impacted on the validity of the results. Furthermore, while the BIS/BAS Scale is the most 
widely used tool for assessing inhibition and activation systems (Demianczyk et al., 2014), 
it was designed as an assessment tool for Gray’s reinforcement sensitivity theory of 
approach and avoidance behaviours in the psychology field (Carver & White, 1994a). It 
does not have any items to account for pain experience or pain-related complaints.  
 
Further limitations of the BIS/BAS Scale itself are the varied number of items per subscale, 
where the BAS subscale includes 13 items compared to the 7 BIS subscale items. 
Additionally, the BAS scale has been split up to allow for individual assessment of BAS-
related traits or Fun Seeking, Reward Responsiveness and Drive, whereas the BIS scale has 
no items relating to specific traits. Hence the scale is not weighted to assess BIS and BAS 
equally.  
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Future Research 
Although there have been attempts to revise the BIS/BAS Scale to improve psychometric 
properties (Demianczyk et al., 2014), it has not been altered or tested for use in pain 
reporting (Jensen et al., 2016). To reiterate a point made by Jensen et al. (2016), the next 
logical step in pursuing this theory is, the development of a measure for BIS/BAS in the 
context of pain. Such an instrument appears to be in development stages (Jensen, Ward, 
Thorn, Ehde, & Day, 2017), but nothing is yet ready for research or clinical use. 
 
Conclusions 
The primary aim of this study was to add to the data published by Jensen et al. (2015) by 
testing whether average intensity and duration of persistent musculoskeletal pain could be 
predicted by behavioural activation and inhibition tendencies, as well as other known 
variables including fear-avoidance beliefs, kinesiophobia and disability.  
 
While this study’s results did not reproduce the purported relationship between BIS, BAS 
and pain intensity, there was a trend toward a significant relationship between high and low 
pain intensity groups and BIS and BAS, such as was found in Jensen et al. (2015). The 
relationship found here between BIS and kinesiophobia was similarly reported in more 
recent literature (Jensen et al., 2017). Furthermore, relationships between pain intensity and 
duration, and kinesiophobia, fear-avoidance beliefs and disability were found consistent 
with the wider literature.  
 
We conclude that the theory of behavioural inhibition and activation systems relating to 
pain may still be valid, regardless of the lack of statistically significant findings in this 
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study. We propose that a revised measure of behavioural inhibition and activation systems 
including items specific to pain experience may reveal more about the relationship and 
have important clinical utility. If a more specific measure were to become available for use 
in managing musculoskeletal pain complaints it could allow for tailoring treatment and 
rehabilitation programmes to better address and avoid chronic pain states. This, in turn, 
could decrease the financial and societal burden caused by pain-related complaints.  
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